furosemide has been researched along with Acute Disease in 295 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study sought to determine the efficacy and safety of a novel, pH-neutral formulation of furosemide administered subcutaneously (SC) for treatment of acute decompensated heart failure (HF)." | 9.27 | Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure. ( Almansa, J; Chambers, J; Chasler, J; Cummings, A; Cuomo, K; Gilotra, NA; Marino, B; Okwuosa, IS; Princewill, O; Rhodes, P; Russell, SD, 2018) |
| "Furosemide is commonly prescribed in acute kidney injury (AKI)." | 9.24 | The effect of low-dose furosemide in critically ill patients with early acute kidney injury: A pilot randomized blinded controlled trial (the SPARK study). ( Bagshaw, SM; Bellomo, R; Gibney, RTN; Hassan, I; Kruger, P; McAlister, FA, 2017) |
| "Furosemide is the most commonly used loop diuretic in patients with heart failure (HF) despite data suggesting potential pharmacologic and antifibrotic benefits with torsemide." | 9.22 | Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial). ( Anstrom, KJ; Armstrong, PW; DeVore, AD; Ezekowitz, JA; Hasselblad, V; Hernandez, AF; Mentz, RJ; Metra, M; O'Connor, CM; Schulte, PJ; Tang, WH; Velazquez, EJ; Voors, AA, 2016) |
| "The Answering question on tolvaptan's efficacy for patients with acute decompensated heart failure and renal failure (AQUAMARINE) is a multicenter, randomized controlled clinical trial, which will enroll 220 patients from 17 hospitals in Japan." | 9.19 | Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study. ( Fujii, H; Matsue, Y; Nagahori, W; Nishioka, T; Noda, M; Okishige, K; Onishi, Y; Ono, Y; Sakurada, H; Satoh, Y; Sugi, K; Suzuki, M; Takahashi, A; Tejima, T; Torii, S; Yamaguchi, S; Yoshida, K, 2014) |
| "Theoretically, salt supplementation should promote diuresis through increasing the glomerular filtration rate (GFR) during treatment of acute decompensated heart failure (ADHF) even with low-dose furosemide; however, there is little evidence to support this idea." | 9.19 | Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure. ( Ando, T; Eguchi, A; Hirotani, S; Iwasaku, T; Manabe, E; Masuyama, T; Morisawa, D; Naito, Y; Nakabo, A; Okuhara, Y; Sawada, H, 2014) |
| "This study was designed to evaluate the consequences of ultrafiltration (UF) and standard intravenous diuretic (furosemide) therapy on glomerular filtration rate (GFR) and renal plasma flow in patients with acute decompensated heart failure." | 9.13 | A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. ( Bock, J; Dowling, TC; Feller, E; Gottlieb, SS; Marshall, J; Robinson, S; Rogers, HL, 2008) |
| "To test the hypothesis that sublingual captopril produces a more rapid improvement of acute pulmonary edema (APE) than does placebo, when added to a standard regimen of O2, nitrates, morphine, and furosemide." | 9.08 | Rapid improvement of acute pulmonary edema with sublingual captopril. ( Carter, WA; Gallagher, EJ; Hamilton, RJ, 1996) |
| "Previous studies have suggested that inhaled furosemide may have a protective effect against a wide variety of bronchoconstrictor agents, but a therapeutic effect has not been established in acute exacerbation of asthma." | 9.08 | Furosemide given by inhalation ameliorates acute exacerbation of asthma. ( Kondo, T; Ohta, Y; Ono, Y; Tanigaki, T, 1997) |
| "Nitrates are superior to furosemide in the management of acute pulmonary edema associated with myocardial infarction; however, their role in the absence of infarction is unclear." | 9.08 | Nitrate therapy is an alternative to furosemide/morphine therapy in the management of acute cardiogenic pulmonary edema. ( Beltrame, JF; Brennan, RJ; Horowitz, JD; Hunt, A; Moran, JL; Unger, SA; Zeitz, CJ, 1998) |
| "As previous studies have suggested that inhaled furosemide may have a protective effect against certain types of provocative challenges in asthmatic subjects, we investigated the role of furosemide in treating acute asthma exacerbations." | 9.07 | Inhaled furosemide is not effective in acute asthma. ( Dworkin, F; Feliciano, S; Hager, D; Karpel, JP; Luks, D; Posner, L; Shapiro, D, 1994) |
| "We have evaluated the effect of oral captopril versus a combination of oral reserpine and frusemide in the treatment of 20 children with post-streptococcal glomerulonephritis (APGN) with hypertension." | 9.07 | Evaluation of captopril versus reserpine and frusemide in treating hypertensive children with acute post-streptococcal glomerulonephritis. ( Anglo, AA; Madina, EH; Morsi, MR; Soliman, AT, 1992) |
| "The immediate haemodynamic effects of intravenous frusemide (1 mg/kg) and intravenous isosorbide dinitrate (50-200 micrograms/kg/h) were compared in a prospective, randomised, between-group study in 28 men with radiographic and haemodynamic evidence of left ventricular failure following acute myocardial infarction." | 9.05 | Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart-failure following myocardial infarction. ( Ahuja, RC; Hussain, M; Nelson, GI; Silke, B; Taylor, SH, 1983) |
| "Continuous versus bolus dosing of furosemide has been a longstanding debate for clinicians treating patients with acute decompensated heart failure." | 8.95 | Which dosing of furosemide is better in acute decompensated heart failure? ( Budavari, AI; Jalaba, S; Palermo, J, 2017) |
| "A short cut review was carried out to establish whether the addition of nebulised furosemide to beta-agonist therapy improves outcomes in acute asthma." | 8.82 | Best evidence topic report. Nebulised furosemide in acute adult asthma. ( Chen, SC; Yen, ZS, 2005) |
| "Door-to-furosemide ≤1 h was associated with a lower short-term risk of heart failure hospitalizations or cardiovascular death in AHF patients." | 8.31 | Door-to-furosemide time and clinical outcomes in acute heart failure. ( Almeida, J; Besteiro, B; Bettencourt, P; Brito, MT; Ferreira, JP; Friões, F; Gomes, F; Gouveia, R; Jardim, AL; Leite-Moreira, A; Marques, P; Vasques-Nóvoa, F; Vieira, JT, 2023) |
| "Furosemide, a loop diuretic, is often empirically used to treat acute decompensated heart failure (ADHF) initially." | 8.31 | Tolvaptan's Association with Low Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease and Acute Decompensated Heart Failure. ( Hasegawa, M; Hayashi, H; Inaguma, D; Koide, S; Ogata, S; Tagaya, T; Takahashi, K; Tsuboi, N; Yuzawa, Y, 2023) |
| "We describe a case of acute pancreatitis (AP) and hypofibrinogenemia associated with drug treatment with the aim to increase awareness of uncommon yet possibly life-threatening adverse reactions of tigecycline and furosemide." | 8.31 | Acute pancreatitis caused by tigecycline and furosemide combination treatment and hypofibrinogenemia caused by tigecycline: A case report. ( Li, ZK; Zheng, P, 2023) |
| "The effect of early administration of intravenous (IV) furosemide in the emergency department (ED) on short-term outcomes of acute heart failure (AHF) patients remains controversial, with one recent Japanese study reporting a decrease of in-hospital mortality and one Korean study reporting a lack of clinical benefit." | 8.02 | The FAST-FURO study: effect of very early administration of intravenous furosemide in the prehospital setting to patients with acute heart failure attending the emergency department. ( Aguiló, S; Álvarez Pérez, JM; Chioncel, O; Fuentes, M; Gil, V; Harjola, P; Harjola, VP; Herrero, P; Jacob, J; Llauger, L; Llorens, P; López-Grima, ML; Martín-Sánchez, FJ; Martínez-Nadal, G; Masip, J; Mebazaa, A; Mir, M; Miró, Ò; Mullens, W; Müller, C; Peacock, WF; Rodríguez-Adrada, E; Rossello, X; Ruschitzka, F; Tost, J, 2021) |
| "We sought to examine whether factors impacting the time to emergency department (ED) administration of intravenous (IV) furosemide were associated with the duration of hospital admission for patients with acute heart failure (AHF)." | 7.88 | Preventable delays to intravenous furosemide administration in the emergency department prolong hospitalization for patients with acute heart failure. ( Collins, SP; Froehle, CM; Liu, D; Ward, MJ, 2018) |
| "Hypertonic saline with furosemide has been proposed for a long time as an effective therapeutic option for the treatment of acute decompensated heart failure (ADHF)." | 7.85 | Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study. ( Ando, T; Hirotani, S; Komamura, K; Mano, T; Masuyama, T; Naito, Y; Nishimura, K; Okuhara, Y; Orihara, Y, 2017) |
| " Physician investigators performed IVC ultrasonography on a convenience sample of 70 hospitalized adults who were prescribed intravenous furosemide for the diagnosis of acute decompensated heart failure." | 7.81 | Inferior vena cava diameter change after intravenous furosemide in patients diagnosed with acute decompensated heart failure. ( Athavale, A; Candotti, C; Katz, A; Kumapley, R; Lucas, BP; Margeta, B; Tchernodrinski, S, 2015) |
| "Systolic heart failure patients with ejection fraction <50% were studied, who, at the treating physician's discretion, received 8-hour infusions of: high dose furosemide (20mg/h), low dose furosemide (5mg/h) or dopamine (5μg/kg/min) combined with furosemide (5mg/h)." | 7.81 | Effects of ventriculoarterial coupling changes on renal function, echocardiographic indices and energy efficiency in patients with acute decompensated systolic heart failure under furosemide and dopamine treatment: a comparison of three therapeutic protoc ( Antoniou, CK; Chrysohoou, C; Lerakis, S; Manolakou, P; Pitsavos, C; Stefanadis, C; Tousoulis, D; Tsioufis, K, 2015) |
| "Treatment of acute decompensated heart failure (ADHF) with loop diuretics, such as furosemide, is frequently complicated by insufficient urine sodium excretion." | 7.80 | Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure. ( Dupont, M; Mullens, W; Shrestha, K; Singh, D; Tang, WH; Testani, JM; Verbrugge, FH, 2014) |
| "Limited data exist comparing the efficacy and safety of bumetanide- or metolazone-based diuretic regimens to furosemide in acute heart failure (HF)." | 7.79 | Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure. ( Elkayam, U; Han, SY; Hshieh, S; Hyderi, AF; Jeng, AI; Kim, BJ; Konopka, E; Lou, M; Ng, TM; Phan, DH; Tsuji, Y, 2013) |
| "Although tolvaptan is a recently approved drug for heart failure and causes aquaresis without affecting renal function, its clinical efficacy for patients with acute decompensated heart failure (ADHF) is yet to be elucidated." | 7.79 | Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population. ( Hashimoto, Y; Iwatsuka, R; Matsue, Y; Matsumura, A; Mizukami, A; Nagahori, W; Ohno, M; Seya, M; Suzuki, M, 2013) |
| "In a comparative clinical trial in 308 patients with acute decompensated heart failure, the relief achieved with intravenous furosemide at a dose equivalent to the daily oral dose patients were receiving prior to the acute episode was very similar to that obtained with higher doses of intravenous furosemide." | 7.78 | Furosemide in acute decompensated heart failure. ( , 2012) |
| "4 solution and furosemide on the outcome of acute pancreatitis patients." | 7.76 | [Role of 6% hydroxyethylstarch 130/0.4 and furosemide in the treatment of acute pancreatitis]. ( Chang, L; Chen, Y; Dong, Y; Feng, S; Hu, W; Lin, J; Wang, J; Zhao, Y; Zhou, P, 2010) |
| "Optimizing responses to intravenous furosemide (ivF) in acute pulmonary edema is limited by current insensitive noninvasive means of volume assessment." | 7.75 | Performing repeated noninvasive bedside measures of volume response to intravenous furosemide in acute pulmonary edema: a feasibility assessment. ( Lip, GY; Macfadyen, RJ; Ng Kam Chuen, MJ, 2009) |
| "The purpose of this economic analysis was to develop an economic model using intra-institutional cost data for acute, oliguric renal insufficiency treated with either an albumin-furosemide complex or albumin followed by furosemide (sequential therapy)." | 7.70 | Pharmacoeconomic comparison of an albumin-furosemide complex versus sequential therapy for renal insufficiency. ( Erstad, BL, 1999) |
| "To evaluate the effects of intravenous furosemide over hemodynamics variables and colloid osmotic pressure in patients with pulmonary edema." | 7.68 | [The effect of intravenous furosemide on the hemodynamic parameters and colloid osmotic pressure in patients with pulmonary edema]. ( César, LA; da Luz, PL; Lage, SG; Mansur, Ade P; Pileggi, F; Ramires, JA; Tsanaclis, A, 1992) |
| "A case of rhabdomyolysis with acute renal failure associated with bezafibrate and furosemide treatment is reported." | 7.68 | [A case of acute rhabdomyolysis and acute renal insufficiency caused by the simultaneous use of furosemide and bezafibrate]. ( Cordi, GC; Corsi, L; Dapelo, M; De Micheli, A; Grimaldi, GP; Venzano, C, 1990) |
| " Rats were divided into four groups as follows: normokalemic control (group I, n = 10), acute hypokalemia with furosemide (group II, n = 16), acute hypokalemia with hyperventilation (group III, n = 18), and chronic hypokalemia induced by a low potassium (K+) diet (group IV, n = 22)." | 7.67 | Hypokalemia in rats produces resistance to dysrhythmias under halothane anesthesia. ( Farina, JP; Kwon, NJ; Stolte, AL, 1989) |
| "Fifty two patients with severe hypertension were treated with parentral chlorpromazine and frusemide." | 7.67 | Chlorpromazine and frusemide in the acute management of severe hypertension. ( Chikanza, IC; Okwanga, PN, 1989) |
| "The favourable effect of gentamicin and its combination with furosemid was shown in treatment of rats with experimental pyelonephritis." | 7.66 | [Use of gentamycin and furosemide in acute pyelonephritis (an experimental morphological study)]. ( Dombrovskaia, AE; Kantariia, VA; Shortanova, TKh, 1980) |
| "A patient is described with acute pancreatitis which was probably caused by furosemide." | 7.65 | Acute pancreatitis secondary to furosemide with associated hyperlipidemia. ( Call, T; Malarkey, WB; Thomas, FB, 1977) |
| "Twenty-five children with the diagnosis of acute glomerulonephritis were treated with oral or intravenous doses of furosemide." | 7.65 | Diuretic effect of furosemide in acute glomerulonephritis. ( Boles, A; Pruitt, AW, 1976) |
| "Haemodynamic measurements were carried out after administration of furosemide to 10 patients suffering from acute myocardial infarction and congestive heart failure." | 7.65 | [Haemodynamic changes in acute myocardial infarction following high doses of furosemide (author's transl)]. ( Kleinberger, G; Kotzaurek, R; Pall, H; Pichler, M; Szeless, ST, 1976) |
| "Treatment with oral diazoxide for periods of 4 to 10 weeks in hospital allowed adequate control of hypertension with continuation of fetal growth in four patients with severe toxaemia." | 7.65 | Successful use of oral diazoxide in the treatment of severe toxaemia of pregnancy. ( Davis, D; Morgan, MY; Pohl, JE; Thurston, H, 1972) |
| "Loop diuretics used in the treatment of heart failure often induce renal impairment." | 6.82 | Early administration of tolvaptan preserves renal function in elderly patients with acute decompensated heart failure. ( Hasegawa, T; Ikeda, U; Izawa, A; Kimura, K; Misawa, T; Momose, T; Morita, T; Motoki, H, 2016) |
| " Although loop diuretics are used in nearly all patients with ADHF to relieve congestive symptoms, optimal dosing strategies remain poorly defined." | 6.75 | Continuous versus intermittent infusion of furosemide in acute decompensated heart failure. ( Dunn, SP; Hollis, IB; Nappi, JM; Rodgers, JE; Thomson, MR; Van Bakel, AB, 2010) |
| "Advanced congestive heart failure (CHF) therapies include intravenous inotropic agents, change in class of diuretics, and venous ultrafiltration or hemodialysis." | 6.50 | Hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis. ( Gandhi, S; Mosleh, W; Myers, RB, 2014) |
| "Diabetes mellitus has been suggested as a determinant of diuretic resistance." | 5.56 | Diabetic patients need higher furosemide doses: a report on acute and chronic heart failure patients. ( Bettencourt, P; Cunha, FM; Lourenço, P; Marques, P; Pereira, J; Ribeiro, A, 2020) |
| "Acute edema was induced in pigs by rapid intravenous injection of 2 000 ml normal saline." | 5.34 | [Diuretic effect of injecting furosemide into low hydraulic resistance point Shuifen along the conception meridian in pigs with acute edema]. ( Gu, SZ; Li, H; Tian, YY; Xie, HH; Zhang, WB, 2007) |
| "On the day of dehydration an intravenous bolus injection of a loop diuretic (furosemide, 1 mg/kg) was superimposed." | 5.31 | Acute effects of moderate dehydration on the hepatic conversion of amino nitrogen into urea nitrogen in healthy men. ( Greisen, J; Ivarsen, P; Vilstrup, H, 2001) |
| "This study sought to determine the efficacy and safety of a novel, pH-neutral formulation of furosemide administered subcutaneously (SC) for treatment of acute decompensated heart failure (HF)." | 5.27 | Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure. ( Almansa, J; Chambers, J; Chasler, J; Cummings, A; Cuomo, K; Gilotra, NA; Marino, B; Okwuosa, IS; Princewill, O; Rhodes, P; Russell, SD, 2018) |
| "In a prospective, randomized, clinical trial, 90 HFpEF patients hospitalized with acute heart failure were randomized within 24 h of admission to 1 of 4 treatments: 1) intravenous bolus furosemide administered every 12 h; 2) continuous infusion furosemide; 3) intermittent bolus furosemide with low-dose dopamine; and 4) continuous infusion furosemide with low-dose dopamine." | 5.27 | Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial. ( Alexander, KM; Chasler, JE; Fine, DM; Gupta, R; Hill, T; Hu, JR; Kalathiya, R; Kass, DA; Kovell, L; Lee, YJ; Miller, J; Montemayor, K; Ndumele, CE; Russell, SD; Schulman, SP; Shah, N; Sharma, K; Sharp, M; Thiemann, DR; Tsao, A; Vaishnav, J; Weiss, RG, 2018) |
| "Furosemide is commonly prescribed in acute kidney injury (AKI)." | 5.24 | The effect of low-dose furosemide in critically ill patients with early acute kidney injury: A pilot randomized blinded controlled trial (the SPARK study). ( Bagshaw, SM; Bellomo, R; Gibney, RTN; Hassan, I; Kruger, P; McAlister, FA, 2017) |
| " high diuretic dose of furosemide in patients with a diagnosis of acute heart failure, BNP ≥ 100 pg/mL, and specific chest X-ray signs." | 5.24 | Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR-AHF. ( Di Somma, S; Nuti, R; Palazzuoli, A; Ruocco, G; Valle, R; Vescovo, G, 2017) |
| "Furosemide is the most commonly used loop diuretic in patients with heart failure (HF) despite data suggesting potential pharmacologic and antifibrotic benefits with torsemide." | 5.22 | Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial). ( Anstrom, KJ; Armstrong, PW; DeVore, AD; Ezekowitz, JA; Hasselblad, V; Hernandez, AF; Mentz, RJ; Metra, M; O'Connor, CM; Schulte, PJ; Tang, WH; Velazquez, EJ; Voors, AA, 2016) |
| " Analyses were performed in 1180 patients enrolled in the Placebo-Controlled Randomized Study of the Selective Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) trial and validated in 1776 patients enrolled in the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) trial." | 5.22 | Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure. ( Bloomfield, DM; Cleland, JG; Cotter, G; Damman, K; Davison, B; Gheorghiade, M; Givertz, MM; Hillege, HL; Metra, M; O'Connor, CM; Ponikowski, P; Subacius, H; Teerlink, JR; Ter Maaten, JM; Valente, MA; van der Meer, P; van Veldhuisen, DJ; Voors, AA, 2016) |
| "The Answering question on tolvaptan's efficacy for patients with acute decompensated heart failure and renal failure (AQUAMARINE) is a multicenter, randomized controlled clinical trial, which will enroll 220 patients from 17 hospitals in Japan." | 5.19 | Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study. ( Fujii, H; Matsue, Y; Nagahori, W; Nishioka, T; Noda, M; Okishige, K; Onishi, Y; Ono, Y; Sakurada, H; Satoh, Y; Sugi, K; Suzuki, M; Takahashi, A; Tejima, T; Torii, S; Yamaguchi, S; Yoshida, K, 2014) |
| "Theoretically, salt supplementation should promote diuresis through increasing the glomerular filtration rate (GFR) during treatment of acute decompensated heart failure (ADHF) even with low-dose furosemide; however, there is little evidence to support this idea." | 5.19 | Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure. ( Ando, T; Eguchi, A; Hirotani, S; Iwasaku, T; Manabe, E; Masuyama, T; Morisawa, D; Naito, Y; Nakabo, A; Okuhara, Y; Sawada, H, 2014) |
| "We examined diuretic response (defined as Δ weight kg/40 mg furosemide) in 1745 hospitalized acute heart failure patients from the PROTECT trial." | 5.19 | Diuretic response in acute heart failure: clinical characteristics and prognostic significance. ( Bloomfield, DM; Cleland, JG; Cotter, G; Damman, K; Davison, B; Dittrich, HC; Fiuzat, M; Givertz, MM; Hillege, HL; Massie, BM; Metra, M; O'Connor, CM; Ponikowski, P; Teerlink, JR; Valente, MA; Van Veldhuisen, DJ; Voors, AA, 2014) |
| "In a prospective, double-blind, randomized trial, we assigned 308 patients with acute decompensated heart failure to receive furosemide administered intravenously by means of either a bolus every 12 hours or continuous infusion and at either a low dose (equivalent to the patient's previous oral dose) or a high dose (2." | 5.15 | Diuretic strategies in patients with acute decompensated heart failure. ( Anstrom, KJ; Bart, BA; Braunwald, E; Bull, DA; Chen, HH; Deswal, A; Felker, GM; Givertz, MM; Goldsmith, SR; Hernandez, AF; Kfoury, AG; Lee, KL; LeWinter, MM; Mascette, AM; McNulty, SE; O'Connor, CM; Ofili, EO; Redfield, MM; Rouleau, JL; Semigran, MJ; Stevenson, LW; Velazquez, EJ, 2011) |
| "This study was designed to evaluate the consequences of ultrafiltration (UF) and standard intravenous diuretic (furosemide) therapy on glomerular filtration rate (GFR) and renal plasma flow in patients with acute decompensated heart failure." | 5.13 | A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. ( Bock, J; Dowling, TC; Feller, E; Gottlieb, SS; Marshall, J; Robinson, S; Rogers, HL, 2008) |
| "To test the hypothesis that sublingual captopril produces a more rapid improvement of acute pulmonary edema (APE) than does placebo, when added to a standard regimen of O2, nitrates, morphine, and furosemide." | 5.08 | Rapid improvement of acute pulmonary edema with sublingual captopril. ( Carter, WA; Gallagher, EJ; Hamilton, RJ, 1996) |
| "Previous studies have suggested that inhaled furosemide may have a protective effect against a wide variety of bronchoconstrictor agents, but a therapeutic effect has not been established in acute exacerbation of asthma." | 5.08 | Furosemide given by inhalation ameliorates acute exacerbation of asthma. ( Kondo, T; Ohta, Y; Ono, Y; Tanigaki, T, 1997) |
| "Patients presenting to mobile emergency units with signs of congestive heart failure were treated with oxygen 10 L/min, intravenous furosemide 40 mg, and morphine 3 mg bolus." | 5.08 | Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. ( Blatt, A; Cotter, G; Faigenberg, Z; Golik, A; Kaluski, E; Koren, M; Marghitay, D; Metzkor, E; Miller, R; Moshkovitz, Y; Shaham, O; Simovitz, A; Zaidenstein, R, 1998) |
| "Nitrates are superior to furosemide in the management of acute pulmonary edema associated with myocardial infarction; however, their role in the absence of infarction is unclear." | 5.08 | Nitrate therapy is an alternative to furosemide/morphine therapy in the management of acute cardiogenic pulmonary edema. ( Beltrame, JF; Brennan, RJ; Horowitz, JD; Hunt, A; Moran, JL; Unger, SA; Zeitz, CJ, 1998) |
| "As previous studies have suggested that inhaled furosemide may have a protective effect against certain types of provocative challenges in asthmatic subjects, we investigated the role of furosemide in treating acute asthma exacerbations." | 5.07 | Inhaled furosemide is not effective in acute asthma. ( Dworkin, F; Feliciano, S; Hager, D; Karpel, JP; Luks, D; Posner, L; Shapiro, D, 1994) |
| "We have evaluated the effect of oral captopril versus a combination of oral reserpine and frusemide in the treatment of 20 children with post-streptococcal glomerulonephritis (APGN) with hypertension." | 5.07 | Evaluation of captopril versus reserpine and frusemide in treating hypertensive children with acute post-streptococcal glomerulonephritis. ( Anglo, AA; Madina, EH; Morsi, MR; Soliman, AT, 1992) |
| "The aim of this open study was to compare the efficacy of Enoximone and conventional treatment in 44 patients with acute pulmonary edema." | 5.06 | [Intravenous enoximone versus conventional treatment in acute lung edema. Preliminary results of a randomized study]. ( Chassing, A; Flammang, D; Tarral, A; Waynberger, M, 1990) |
| "The immediate haemodynamic effects of intravenous frusemide (1 mg/kg) and intravenous isosorbide dinitrate (50-200 micrograms/kg/h) were compared in a prospective, randomised, between-group study in 28 men with radiographic and haemodynamic evidence of left ventricular failure following acute myocardial infarction." | 5.05 | Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart-failure following myocardial infarction. ( Ahuja, RC; Hussain, M; Nelson, GI; Silke, B; Taylor, SH, 1983) |
| "Continuous versus bolus dosing of furosemide has been a longstanding debate for clinicians treating patients with acute decompensated heart failure." | 4.95 | Which dosing of furosemide is better in acute decompensated heart failure? ( Budavari, AI; Jalaba, S; Palermo, J, 2017) |
| "Administering intermittent boluses of furosemide to patients with acute decompensated heart failure (ADHF) often leads to unfavorable hemodynamic changes." | 4.88 | Continuous infusion versus intermittent bolus furosemide in ADHF: an updated meta-analysis of randomized control trials. ( Adomaityte, J; Amer, M; Qayyum, R, 2012) |
| "A mainstay of therapy for congestive heart failure has been the use of potent diuretic agents, such as furosemide, that target the kidney to enhance sodium and water excretion." | 4.84 | Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators. ( Burnett, JC; Cataliotti, A; Chen, HH; Martin, FL, 2008) |
| "A short cut review was carried out to establish whether the addition of nebulised furosemide to beta-agonist therapy improves outcomes in acute asthma." | 4.82 | Best evidence topic report. Nebulised furosemide in acute adult asthma. ( Chen, SC; Yen, ZS, 2005) |
| "Door-to-furosemide ≤1 h was associated with a lower short-term risk of heart failure hospitalizations or cardiovascular death in AHF patients." | 4.31 | Door-to-furosemide time and clinical outcomes in acute heart failure. ( Almeida, J; Besteiro, B; Bettencourt, P; Brito, MT; Ferreira, JP; Friões, F; Gomes, F; Gouveia, R; Jardim, AL; Leite-Moreira, A; Marques, P; Vasques-Nóvoa, F; Vieira, JT, 2023) |
| "Furosemide, a loop diuretic, is often empirically used to treat acute decompensated heart failure (ADHF) initially." | 4.31 | Tolvaptan's Association with Low Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease and Acute Decompensated Heart Failure. ( Hasegawa, M; Hayashi, H; Inaguma, D; Koide, S; Ogata, S; Tagaya, T; Takahashi, K; Tsuboi, N; Yuzawa, Y, 2023) |
| "We describe a case of acute pancreatitis (AP) and hypofibrinogenemia associated with drug treatment with the aim to increase awareness of uncommon yet possibly life-threatening adverse reactions of tigecycline and furosemide." | 4.31 | Acute pancreatitis caused by tigecycline and furosemide combination treatment and hypofibrinogenemia caused by tigecycline: A case report. ( Li, ZK; Zheng, P, 2023) |
| "The effect of early administration of intravenous (IV) furosemide in the emergency department (ED) on short-term outcomes of acute heart failure (AHF) patients remains controversial, with one recent Japanese study reporting a decrease of in-hospital mortality and one Korean study reporting a lack of clinical benefit." | 4.02 | The FAST-FURO study: effect of very early administration of intravenous furosemide in the prehospital setting to patients with acute heart failure attending the emergency department. ( Aguiló, S; Álvarez Pérez, JM; Chioncel, O; Fuentes, M; Gil, V; Harjola, P; Harjola, VP; Herrero, P; Jacob, J; Llauger, L; Llorens, P; López-Grima, ML; Martín-Sánchez, FJ; Martínez-Nadal, G; Masip, J; Mebazaa, A; Mir, M; Miró, Ò; Mullens, W; Müller, C; Peacock, WF; Rodríguez-Adrada, E; Rossello, X; Ruschitzka, F; Tost, J, 2021) |
| "We sought to examine whether factors impacting the time to emergency department (ED) administration of intravenous (IV) furosemide were associated with the duration of hospital admission for patients with acute heart failure (AHF)." | 3.88 | Preventable delays to intravenous furosemide administration in the emergency department prolong hospitalization for patients with acute heart failure. ( Collins, SP; Froehle, CM; Liu, D; Ward, MJ, 2018) |
| "Hypertonic saline with furosemide has been proposed for a long time as an effective therapeutic option for the treatment of acute decompensated heart failure (ADHF)." | 3.85 | Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study. ( Ando, T; Hirotani, S; Komamura, K; Mano, T; Masuyama, T; Naito, Y; Nishimura, K; Okuhara, Y; Orihara, Y, 2017) |
| "Approximately one-third of patients with acute decompensated heart failure (ADHF) treated with an intravenous (iv) loop diuretic at a relatively high dose (>80 mg/day of furosemide, or an equivalent dose of another loop diuretic), exhibit worsening renal function (WRF) after a single course of iv infusions or iv bolus injections maintained for several days." | 3.83 | Poor concordance between different definitions of worsening renal function in patients with acute exacerbation of chronic heart failure: a retrospective study. ( Baldi, C; De Vecchis, R; Di Biase, G, 2016) |
| "A 21-year-old African American woman in her 17th week of pregnancy presented with acute angle-closure glaucoma in both eyes after being started on furosemide in her first trimester for fluid overload." | 3.83 | Presumed Furosemide-associated Bilateral Angle-Closure Glaucoma. ( Boundaoui, ON; Woodruff, TE, 2016) |
| " Physician investigators performed IVC ultrasonography on a convenience sample of 70 hospitalized adults who were prescribed intravenous furosemide for the diagnosis of acute decompensated heart failure." | 3.81 | Inferior vena cava diameter change after intravenous furosemide in patients diagnosed with acute decompensated heart failure. ( Athavale, A; Candotti, C; Katz, A; Kumapley, R; Lucas, BP; Margeta, B; Tchernodrinski, S, 2015) |
| "Systolic heart failure patients with ejection fraction <50% were studied, who, at the treating physician's discretion, received 8-hour infusions of: high dose furosemide (20mg/h), low dose furosemide (5mg/h) or dopamine (5μg/kg/min) combined with furosemide (5mg/h)." | 3.81 | Effects of ventriculoarterial coupling changes on renal function, echocardiographic indices and energy efficiency in patients with acute decompensated systolic heart failure under furosemide and dopamine treatment: a comparison of three therapeutic protoc ( Antoniou, CK; Chrysohoou, C; Lerakis, S; Manolakou, P; Pitsavos, C; Stefanadis, C; Tousoulis, D; Tsioufis, K, 2015) |
| "Treatment of acute decompensated heart failure (ADHF) with loop diuretics, such as furosemide, is frequently complicated by insufficient urine sodium excretion." | 3.80 | Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure. ( Dupont, M; Mullens, W; Shrestha, K; Singh, D; Tang, WH; Testani, JM; Verbrugge, FH, 2014) |
| "Limited data exist comparing the efficacy and safety of bumetanide- or metolazone-based diuretic regimens to furosemide in acute heart failure (HF)." | 3.79 | Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure. ( Elkayam, U; Han, SY; Hshieh, S; Hyderi, AF; Jeng, AI; Kim, BJ; Konopka, E; Lou, M; Ng, TM; Phan, DH; Tsuji, Y, 2013) |
| "Although tolvaptan is a recently approved drug for heart failure and causes aquaresis without affecting renal function, its clinical efficacy for patients with acute decompensated heart failure (ADHF) is yet to be elucidated." | 3.79 | Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population. ( Hashimoto, Y; Iwatsuka, R; Matsue, Y; Matsumura, A; Mizukami, A; Nagahori, W; Ohno, M; Seya, M; Suzuki, M, 2013) |
| "In a comparative clinical trial in 308 patients with acute decompensated heart failure, the relief achieved with intravenous furosemide at a dose equivalent to the daily oral dose patients were receiving prior to the acute episode was very similar to that obtained with higher doses of intravenous furosemide." | 3.78 | Furosemide in acute decompensated heart failure. ( , 2012) |
| "4 solution and furosemide on the outcome of acute pancreatitis patients." | 3.76 | [Role of 6% hydroxyethylstarch 130/0.4 and furosemide in the treatment of acute pancreatitis]. ( Chang, L; Chen, Y; Dong, Y; Feng, S; Hu, W; Lin, J; Wang, J; Zhao, Y; Zhou, P, 2010) |
| "Optimizing responses to intravenous furosemide (ivF) in acute pulmonary edema is limited by current insensitive noninvasive means of volume assessment." | 3.75 | Performing repeated noninvasive bedside measures of volume response to intravenous furosemide in acute pulmonary edema: a feasibility assessment. ( Lip, GY; Macfadyen, RJ; Ng Kam Chuen, MJ, 2009) |
| "Colchicine poisoning is an uncommon, but potentially life-threatening, toxicologic emergency." | 3.74 | Acute colchicine intoxication in a child: a case report. ( Biçer, S; Ctak, A; Karaböcüoğlu, M; Soysal, DD; Uçsel, R; Uzel, N, 2007) |
| "The purpose of this economic analysis was to develop an economic model using intra-institutional cost data for acute, oliguric renal insufficiency treated with either an albumin-furosemide complex or albumin followed by furosemide (sequential therapy)." | 3.70 | Pharmacoeconomic comparison of an albumin-furosemide complex versus sequential therapy for renal insufficiency. ( Erstad, BL, 1999) |
| "To evaluate the effects of intravenous furosemide over hemodynamics variables and colloid osmotic pressure in patients with pulmonary edema." | 3.68 | [The effect of intravenous furosemide on the hemodynamic parameters and colloid osmotic pressure in patients with pulmonary edema]. ( César, LA; da Luz, PL; Lage, SG; Mansur, Ade P; Pileggi, F; Ramires, JA; Tsanaclis, A, 1992) |
| "Plasma ANF, renin activity, urinary aldosterone and catecholamine levels were evaluated in 10 patients with congestive heart failure (at baseline, after 15 days of adequate treatment with digoxin and diuretics, and after 45 days of enalapril) in order to assess the changes of ANF and vasoconstrictor neurohormones with chronic Ace inhibitor therapy." | 3.68 | [Atrial natriuretic factor in patients with cardiac decompensation before and after chronic therapy with an angiotensin-converting enzyme inhibitor]. ( Gribaldo, R; Lupia, M; Opocher, G; Pomini, G; Rugna, A, 1992) |
| "A case of rhabdomyolysis with acute renal failure associated with bezafibrate and furosemide treatment is reported." | 3.68 | [A case of acute rhabdomyolysis and acute renal insufficiency caused by the simultaneous use of furosemide and bezafibrate]. ( Cordi, GC; Corsi, L; Dapelo, M; De Micheli, A; Grimaldi, GP; Venzano, C, 1990) |
| " Rats were divided into four groups as follows: normokalemic control (group I, n = 10), acute hypokalemia with furosemide (group II, n = 16), acute hypokalemia with hyperventilation (group III, n = 18), and chronic hypokalemia induced by a low potassium (K+) diet (group IV, n = 22)." | 3.67 | Hypokalemia in rats produces resistance to dysrhythmias under halothane anesthesia. ( Farina, JP; Kwon, NJ; Stolte, AL, 1989) |
| "Fifty two patients with severe hypertension were treated with parentral chlorpromazine and frusemide." | 3.67 | Chlorpromazine and frusemide in the acute management of severe hypertension. ( Chikanza, IC; Okwanga, PN, 1989) |
| "The favourable effect of gentamicin and its combination with furosemid was shown in treatment of rats with experimental pyelonephritis." | 3.66 | [Use of gentamycin and furosemide in acute pyelonephritis (an experimental morphological study)]. ( Dombrovskaia, AE; Kantariia, VA; Shortanova, TKh, 1980) |
| "A patient is described with acute pancreatitis which was probably caused by furosemide." | 3.65 | Acute pancreatitis secondary to furosemide with associated hyperlipidemia. ( Call, T; Malarkey, WB; Thomas, FB, 1977) |
| "Twenty-five children with the diagnosis of acute glomerulonephritis were treated with oral or intravenous doses of furosemide." | 3.65 | Diuretic effect of furosemide in acute glomerulonephritis. ( Boles, A; Pruitt, AW, 1976) |
| "Haemodynamic measurements were carried out after administration of furosemide to 10 patients suffering from acute myocardial infarction and congestive heart failure." | 3.65 | [Haemodynamic changes in acute myocardial infarction following high doses of furosemide (author's transl)]. ( Kleinberger, G; Kotzaurek, R; Pall, H; Pichler, M; Szeless, ST, 1976) |
| "Treatment with oral diazoxide for periods of 4 to 10 weeks in hospital allowed adequate control of hypertension with continuation of fetal growth in four patients with severe toxaemia." | 3.65 | Successful use of oral diazoxide in the treatment of severe toxaemia of pregnancy. ( Davis, D; Morgan, MY; Pohl, JE; Thurston, H, 1972) |
| "The very early management of pulmonary embolism (PE), a part from antithrombotic treatment, has been little studied." | 3.11 | Diuretics Versus Volume Expansion in the Initial Management of Acute Intermediate High-Risk Pulmonary Embolism. ( Asarisi, F; Berkane, N; Breittmayer, JP; Bun, S; Doyen, D; Ferrari, E; Fourrier, E; Heme, N; Labbaoui, M; Moceri, P; Redjimi, N; Sartre, B; Squara, F, 2022) |
| " The lower Na and SBP in this instance should not lead to withholding or minimising diuretic dosage which should rather be dictated by volume status." | 2.94 | Higher Diuretic Requirements in Acute Heart Failure With Admission Hyponatraemia Versus Normonatraemia. ( Guglin, M; Omar, HR, 2020) |
| "Furosemide treatment on admission was well tolerated, and was not associated with serious adverse events." | 2.84 | Diuretics versus volume expansion in acute submassive pulmonary embolism. ( Bouvier, P; Cerboni, P; Chiche, O; Doyen, D; Ferrari, E; Moceri, P; Schouver, ED, 2017) |
| "Loop diuretics used in the treatment of heart failure often induce renal impairment." | 2.82 | Early administration of tolvaptan preserves renal function in elderly patients with acute decompensated heart failure. ( Hasegawa, T; Ikeda, U; Izawa, A; Kimura, K; Misawa, T; Momose, T; Morita, T; Motoki, H, 2016) |
| "Intravenous loop diuretics are still the cornerstone of therapy in acute decompensated heart failure, however, the optimal dosage and administration strategies remain poorly defined particularly in patients with an associated renal dysfunction." | 2.80 | Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction. ( Angelini, GD; Beltrami, M; Franci, B; Gonnelli, S; Nuti, R; Palazzuoli, A; Pellegrini, M; Ruocco, G, 2015) |
| "Results from the DOSE-AHF study suggest that an initial continuous infusion of loop diuretics is not superior to bolus dosing with regard to clinical endpoints in acute heart failure." | 2.77 | Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure. ( Braunwald, E; Felker, GM; Givertz, MM; McNulty, S; O'Connor, CM; Shah, RV, 2012) |
| " Although loop diuretics are used in nearly all patients with ADHF to relieve congestive symptoms, optimal dosing strategies remain poorly defined." | 2.75 | Continuous versus intermittent infusion of furosemide in acute decompensated heart failure. ( Dunn, SP; Hollis, IB; Nappi, JM; Rodgers, JE; Thomson, MR; Van Bakel, AB, 2010) |
| "Advanced congestive heart failure (CHF) therapies include intravenous inotropic agents, change in class of diuretics, and venous ultrafiltration or hemodialysis." | 2.50 | Hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis. ( Gandhi, S; Mosleh, W; Myers, RB, 2014) |
| "Although treatment of acute heart failure is based primarily on the administration of intravenous loop diuretics, evidence supporting this practice is still scarce and there is uncertainty about the optimal dose." | 2.50 | [Alternatives to conventional diuretic therapy in heart failure]. ( Formiga, F; Morales-Rull, JL; Trullàs, JC, 2014) |
| " Despite being available for decades, few randomized trials exist to guide dosing and administration of these drugs." | 2.48 | Diuretic dosing in acute decompensated heart failure: lessons from DOSE. ( Campbell, PT; Ryan, J, 2012) |
| "Levosimendan has shown lower mortality compared to dobutamine in patients with acute congestive heart failure." | 2.43 | [Medical and ventilatory treatment of acute heart failure]. ( Atar, D; Hodt, A; Steine, K, 2006) |
| "The cardiorenal syndrome is not well understood, and a uniform definition is lacking." | 2.43 | Acute decompensated heart failure: the cardiorenal syndrome. ( Francis, G, 2006) |
| "There is substantial variability amongst physicians and between cardiologists and non-cardiologists in the management of patients with ADHF, with regard to clinical parameters used to tailor treatment, treatment goals, diuretic dosing and escalation strategies." | 1.91 | Decongestion strategies in patients presenting with acutely decompensated heart failure: A worldwide survey among physicians. ( Agaoglu, E; Chioncel, O; Coats, AJS; Filippatos, G; Kapelios, CJ; Lopatin, Y; Metra, M; Mullens, W; Rosano, G; Seferovic, P; Vazir, A, 2023) |
| "Diabetes mellitus has been suggested as a determinant of diuretic resistance." | 1.56 | Diabetic patients need higher furosemide doses: a report on acute and chronic heart failure patients. ( Bettencourt, P; Cunha, FM; Lourenço, P; Marques, P; Pereira, J; Ribeiro, A, 2020) |
| "Hyponatremia is the most common electrolyte abnormality found in hospitalized patients with acute heart failure (AHF) and is related to poor prognosis." | 1.48 | Hyponatremia in Acute Heart Failure in Relation to Hematocrit Levels: Clinical Relevance and Prognostic Implication. ( Nuti, R; Palazzuoli, A; Ruocco, G; Verbrugge, FH, 2018) |
| "One of the risks of diuretic therapy for pulmonary edema is the development of hyponatremia and hypokalemia with pro-arrhythmic potential." | 1.43 | [Diuretic treatment in patients with acute pulmonary edema did not produces severe hyponatremia or hypokalemia]. ( Bodíková, S; Kalužay, J; Pokorná, V; Ponťuch, P; Vahančíková, N, 2016) |
| "The paper describes a case of severe preranal acute renal failure that was induced by the uncontrolled long-term use of furosemide and that was reversible after infusion therapy." | 1.40 | [The specific features of kidney injury due to abuse of saluretics and uncontrollable fasting in anorexia nervosa]. ( Nikolaev, AIu; Tareeva, AB; Zakharova, EV, 2014) |
| "furosemide dose or were switched furosemide to oral route (fast diuretic response, FDR)." | 1.39 | Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors. ( Almeida, S; Bettencourt, P; Carvalho, H; Ferreira, JP; Marques, I; Santos, M, 2013) |
| "Nitrates were given most often in pulmonary oedema and hypertensive AHF." | 1.39 | Management of acute heart failure and the effect of systolic blood pressure on the use of intravenous therapies. ( Harjola, VP; Lassus, J; Nieminen, MS; Siirilä-Waris, K; Tarvasmäki, T; Tolonen, J, 2013) |
| "During pregnancy, acute respiratory failure and pulmonary oedema are not uncommon life-threatening events." | 1.39 | Lung ultrasound-guided management of acute breathlessness during pregnancy. ( Bourgoin, A; Contargyris, C; Gavage, L; Lagier, D; Leone, M; Martin, C; Zieleskiewicz, L, 2013) |
| " A post-hoc analysis was performed to determine if there was an interaction between intravenous (iv) bolus diuretic dosing and outcomes." | 1.37 | Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis. ( Follath, F; Gayat, E; Laribi, S; Lassus, J; Mebazaa, A; Nikolaou, M; Parissis, J; Peacock, WF; Salem, R; Yilmaz, MB, 2011) |
| "Nitroglycerine was the most commonly used antihypertensive treatment overall (40% of patients), followed by urapidil (21%), clonidine (16%) and furosemide (8%)." | 1.37 | Characteristics, practice patterns, and outcomes in patients with acute hypertension: European registry for Studying the Treatment of Acute hyperTension (Euro-STAT). ( Anderson, FA; de La Garanderie, DP; Emery, L; Gore, JM; Rushton-Smith, S; Vincent, JL; Vuylsteke, A; Wyman, A, 2011) |
| "Rural management of acute cardiogenic pulmonary edema should be based on avoidance of adverse outcomes such as in-hospital mortality, the need for intensive care unit care, and the need for intubation and mechanical ventilation." | 1.35 | Rural treatment of acute cardiogenic pulmonary edema: applying the evidence to achieve success with failure. ( Bosomworth, J, 2008) |
| "Acute edema was induced in pigs by rapid intravenous injection of 2 000 ml normal saline." | 1.34 | [Diuretic effect of injecting furosemide into low hydraulic resistance point Shuifen along the conception meridian in pigs with acute edema]. ( Gu, SZ; Li, H; Tian, YY; Xie, HH; Zhang, WB, 2007) |
| " Animals were divided into four groups (n = 6 each): (1) sham-operated group infused with saline; (2) sham-operated group infused with 30 microg/kg/hr furosemide (equivalent to a human dosage of 2 mg/hr); (3) unilateral renal ischemia (1 hr, left renal artery cross-clamping) followed by 6 hr of reperfusion; and (4) renal ischemia/ reperfusion (I/R) with furosemide." | 1.33 | Effect of furosemide infusion on renal hemodynamics and angiogenesis gene expression in acute renal ischemia/reperfusion. ( Aravindan, N; Shaw, A, 2006) |
| "Furosemide is a potent diuretic that affects water transfer across the respiratory epithelium, which is closely related to the transepithelial potential difference (PD)." | 1.32 | Effects of acute hypovolaemia by furosemide on tracheal transepithelial potential difference and mucus in dogs. ( Auler-Júnior, JO; Donato-Júnior, F; King, M; Kondo, CS; Lorenzi-Filho, G; Nakagawa, NK; Saldiva, PH, 2004) |
| "Coxiella burnetii myocarditis is a rare but severe clinical form of acute Q fever." | 1.31 | [Acute myocardial failure in a young man: Q-fever myocarditis]. ( Climent, V; López, I; Manso, MI; Murcia, J; Reus, S; Tello, A, 2002) |
| "While hyporeninemic hypoaldosteronism (HH) has been well described in relation to chronic renal diseases, transient HH has rarely been reported." | 1.31 | Transient hyporeninemic hypoaldosteronism in acute glomerulonephritis. ( Nitta, K; Watanabe, T, 2002) |
| "On the day of dehydration an intravenous bolus injection of a loop diuretic (furosemide, 1 mg/kg) was superimposed." | 1.31 | Acute effects of moderate dehydration on the hepatic conversion of amino nitrogen into urea nitrogen in healthy men. ( Greisen, J; Ivarsen, P; Vilstrup, H, 2001) |
| "Acute heart failure is a life-threatening medical emergency, most commonly occurring as an immediate or delayed complication of acute myocardial infarction (AMI), or resulting from severe hypertension or valvular defects (stenosis or incompetence)." | 1.31 | A case report of acute heart failure caused by a patient delaying taking his diuretic medication. ( Chapman, PJ, 2002) |
| "Among 1613 patients treated for acute pancreatitis in 1993, drug induced acute pancreatitis was diagnosed in 22 patients (incidence 1." | 1.29 | Drug induced acute pancreatitis: incidence and severity. ( Dröge, M; Gottesleben, F; Lankisch, PG, 1995) |
| "A case of systemic lupus erythematosus (SLE) associated with fever, heart failure, and left ventricular (LV) aneurysm is reported." | 1.29 | Acute myocarditis and left ventricular aneurysm as presentations of systemic lupus erythematosus. ( Caldarulo, M; Frustaci, A; Gentiloni, N, 1996) |
| "Transient hyperkalemia has been reported to occur in patients with acute glomerulonephritis, but the pathogenetic mechanism has not been investigated systematically." | 1.28 | Hyperkalemia in acute glomerulonephritis due to transient hyporeninemic hypoaldosteronism. ( Don, BR; Schambelan, M, 1990) |
| "Experimental vasogenic cerebral edema was created in rabbits with a cold-induced left occipital cortical lesions." | 1.26 | Acute therapeutic modalities for experimental vasogenic edema. ( Harbaugh, RD; James, HE; Laurin, R; Marshall, LF; Shapiro, HM, 1979) |
| "Following onset of acute cardiogenic pulmonary edema in 21 patients, increases in hematocrit, plasma protein concentration, and colloid osmotic pressure were associated with decreases in plasma volume." | 1.26 | Blood volume prior to and following treatment of acute cardiogenic pulmonary edema. ( Figueras, J; Weil, MH, 1978) |
| "The treatment of acute cardiogenic pulmonary edema is associated with the return of hypo-oncotic fluid from the interstitial compartment back into the intravascular compartment with expansion of plasma volume and reduction of colloid osmotic pressure and hemoglobin concentration." | 1.26 | Effect of afterload reduction on plasma volume during acute heart failure. ( Henning, RJ; Weil, MH, 1978) |
| "Following treatment of pulmonary edema in 76 patients with furosemide, morphine, and oxygen, pulmonary edema was reversed in 65 patients." | 1.26 | Increases in plasma oncotic pressure during acute cardiogenic pulmonary edema. ( Figueras, J; Weil, MH, 1977) |
| " The regime used was spironolactone in a dosage of 25 mg three times a day for two days preceding and during the periods spent at altitudes above 3,000 m." | 1.26 | Spironolactone and acute mountain sickness. ( Carter, PH; Champion, WL; Currie, TT; Fong, G; Francis, JK; McDonald, IH; Newing, RK; Nunn, IN; Sisson, RN; Sussex, M; Zacharin, RF, 1976) |
| "Fifty-two cases of acute renal failure at Livingstone Hospital were studied." | 1.26 | Acute renal failure. Experience with 52 patients treated at Livingstone Hospital. ( Naidoo, PM, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 120 (40.68) | 18.7374 |
| 1990's | 35 (11.86) | 18.2507 |
| 2000's | 36 (12.20) | 29.6817 |
| 2010's | 89 (30.17) | 24.3611 |
| 2020's | 15 (5.08) | 2.80 |
| Authors | Studies |
|---|---|
| Lim, P | 3 |
| Delmas, C | 1 |
| Sanchez, O | 1 |
| Meneveau, N | 1 |
| Rosario, R | 1 |
| Bouvaist, H | 1 |
| Bernard, A | 1 |
| Mansourati, J | 1 |
| Couturaud, F | 1 |
| Sebbane, M | 1 |
| Coste, P | 1 |
| Rohel, G | 1 |
| Tardy, B | 1 |
| Biendel, C | 1 |
| Lairez, O | 1 |
| Ivanes, F | 1 |
| Gallet, R | 3 |
| Dubois-Rande, JL | 2 |
| Fard, D | 1 |
| Chatelier, G | 1 |
| Simon, T | 2 |
| Paul, M | 1 |
| Natella, PA | 1 |
| Layese, R | 1 |
| Bastuji-Garin, S | 1 |
| Ferrari, E | 2 |
| Sartre, B | 1 |
| Labbaoui, M | 1 |
| Heme, N | 1 |
| Asarisi, F | 1 |
| Redjimi, N | 1 |
| Fourrier, E | 1 |
| Squara, F | 1 |
| Bun, S | 1 |
| Berkane, N | 1 |
| Breittmayer, JP | 1 |
| Doyen, D | 2 |
| Moceri, P | 2 |
| Dotare, T | 1 |
| Maeda, D | 1 |
| Matsue, Y | 6 |
| Sunayama, T | 1 |
| Kida, K | 3 |
| Kitai, T | 3 |
| Kagiyama, N | 4 |
| Yamaguchi, T | 3 |
| Okumura, T | 3 |
| Mizuno, A | 3 |
| Oishi, S | 3 |
| Inuzuka, Y | 3 |
| Akiyama, E | 3 |
| Suzuki, S | 3 |
| Yamamoto, M | 3 |
| Minamino, T | 1 |
| Goncalvesova, E | 1 |
| Dankova, M | 1 |
| Lesny, P | 1 |
| Luknar, M | 1 |
| Marques, P | 2 |
| Brito, MT | 1 |
| Vasques-Nóvoa, F | 1 |
| Ferreira, JP | 3 |
| Jardim, AL | 1 |
| Gouveia, R | 1 |
| Besteiro, B | 1 |
| Vieira, JT | 1 |
| Gomes, F | 1 |
| Leite-Moreira, A | 1 |
| Bettencourt, P | 4 |
| Almeida, J | 1 |
| Friões, F | 1 |
| Tagaya, T | 1 |
| Hayashi, H | 1 |
| Ogata, S | 2 |
| Takahashi, K | 1 |
| Koide, S | 1 |
| Inaguma, D | 1 |
| Hasegawa, M | 1 |
| Yuzawa, Y | 1 |
| Tsuboi, N | 1 |
| Li, ZK | 1 |
| Zheng, P | 1 |
| Vazir, A | 1 |
| Kapelios, CJ | 1 |
| Agaoglu, E | 1 |
| Metra, M | 6 |
| Lopatin, Y | 1 |
| Seferovic, P | 1 |
| Mullens, W | 4 |
| Filippatos, G | 2 |
| Rosano, G | 1 |
| Coats, AJS | 1 |
| Chioncel, O | 2 |
| Al-Ani, MA | 1 |
| Schwartz, C | 1 |
| Winchester, D | 1 |
| Barry, J | 1 |
| Cerda, M | 1 |
| Aranda, JM | 1 |
| Ahmed, MM | 1 |
| Cunha, FM | 1 |
| Pereira, J | 1 |
| Ribeiro, A | 1 |
| Lourenço, P | 1 |
| Griffin, M | 1 |
| Soufer, A | 1 |
| Goljo, E | 1 |
| Colna, M | 1 |
| Rao, VS | 1 |
| Jeon, S | 1 |
| Raghavendra, P | 1 |
| D'Ambrosi, J | 1 |
| Riello, R | 1 |
| Coca, SG | 1 |
| Mahoney, D | 1 |
| Jacoby, D | 1 |
| Ahmad, T | 1 |
| Chen, M | 1 |
| Tang, WHW | 2 |
| Turner, J | 1 |
| Wilson, FP | 1 |
| Testani, JM | 4 |
| Freund, Y | 1 |
| Cachanado, M | 1 |
| Delannoy, Q | 1 |
| Laribi, S | 3 |
| Yordanov, Y | 1 |
| Gorlicki, J | 1 |
| Chouihed, T | 2 |
| Féral-Pierssens, AL | 1 |
| Truchot, J | 1 |
| Desmettre, T | 1 |
| Occelli, C | 1 |
| Bobbia, X | 1 |
| Khellaf, M | 1 |
| Ganansia, O | 1 |
| Bokobza, J | 1 |
| Balen, F | 1 |
| Beaune, S | 1 |
| Bloom, B | 1 |
| Mebazaa, A | 3 |
| Miró, Ò | 2 |
| Harjola, P | 1 |
| Rossello, X | 1 |
| Gil, V | 2 |
| Jacob, J | 2 |
| Llorens, P | 2 |
| Martín-Sánchez, FJ | 2 |
| Herrero, P | 2 |
| Martínez-Nadal, G | 1 |
| Aguiló, S | 1 |
| López-Grima, ML | 1 |
| Fuentes, M | 1 |
| Álvarez Pérez, JM | 1 |
| Rodríguez-Adrada, E | 1 |
| Mir, M | 1 |
| Tost, J | 1 |
| Llauger, L | 1 |
| Ruschitzka, F | 1 |
| Harjola, VP | 2 |
| Masip, J | 1 |
| Peacock, WF | 2 |
| Müller, C | 1 |
| Mikami, T | 1 |
| Ishii, M | 1 |
| Yamamoto, N | 1 |
| Marume, K | 1 |
| Nakai, M | 1 |
| Kaichi, R | 1 |
| Ikebe, S | 1 |
| Mori, T | 1 |
| Komaki, S | 1 |
| Kusaka, H | 1 |
| Toida, R | 1 |
| Kurogi, K | 1 |
| Iwanaga, Y | 1 |
| Ogawa, H | 1 |
| Miyamoto, Y | 1 |
| Tsujita, K | 1 |
| García-Blas, S | 1 |
| Bonanad, C | 1 |
| Llàcer, P | 2 |
| Ventura, S | 2 |
| Núñez, JM | 1 |
| Sánchez, R | 1 |
| Chamorro, C | 1 |
| Fácila, L | 1 |
| de la Espriella, R | 1 |
| Vaquer, JM | 1 |
| Cordero, A | 1 |
| Roqué, M | 1 |
| Ortiz, V | 1 |
| Racugno, P | 1 |
| Bodí, V | 2 |
| Valero, E | 1 |
| Santas, E | 1 |
| Moreno, MDC | 1 |
| Miñana, G | 2 |
| Carratalá, A | 1 |
| Bondanza, L | 1 |
| Payá, A | 1 |
| Cardells, I | 1 |
| Heredia, R | 1 |
| Pellicer, M | 1 |
| Valls, G | 1 |
| Palau, P | 2 |
| Bosch, MJ | 1 |
| Raso, R | 1 |
| Sánchez, A | 1 |
| Bertomeu-González, V | 2 |
| Bertomeu-Martínez, V | 1 |
| Montagud-Balaguer, V | 1 |
| Albiach-Montañana, C | 1 |
| Pendás-Meneau, J | 1 |
| Marcaida, G | 1 |
| Cervantes-García, S | 1 |
| San Antonio, R | 1 |
| de Mingo, E | 1 |
| Chorro, FJ | 2 |
| Sanchis, J | 2 |
| Núñez, J | 2 |
| Lee, G | 1 |
| Pickstone, N | 1 |
| Facultad, J | 1 |
| Titchener, K | 1 |
| Damman, K | 5 |
| Voors, AA | 8 |
| Kuroda, S | 2 |
| Matsukawa, R | 2 |
| Kato, K | 2 |
| Naruke, T | 2 |
| Yoshioka, K | 2 |
| Miyoshi, T | 2 |
| Baba, Y | 2 |
| Murai, K | 2 |
| Mizutani, K | 2 |
| Yoshida, K | 5 |
| Yan, S | 1 |
| Yu, J | 1 |
| Xia, Z | 1 |
| Zhu, B | 1 |
| Hu, J | 1 |
| Li, J | 1 |
| Bagshaw, SM | 2 |
| Gibney, RTN | 1 |
| Kruger, P | 1 |
| Hassan, I | 1 |
| McAlister, FA | 2 |
| Bellomo, R | 2 |
| Ng, KT | 1 |
| Yap, JLL | 1 |
| Palazzuoli, A | 4 |
| Ruocco, G | 4 |
| Vescovo, G | 1 |
| Valle, R | 1 |
| Di Somma, S | 1 |
| Nuti, R | 4 |
| Schouver, ED | 1 |
| Chiche, O | 1 |
| Bouvier, P | 1 |
| Cerboni, P | 1 |
| Gilotra, NA | 1 |
| Princewill, O | 1 |
| Marino, B | 1 |
| Okwuosa, IS | 1 |
| Chasler, J | 1 |
| Almansa, J | 1 |
| Cummings, A | 1 |
| Rhodes, P | 1 |
| Chambers, J | 1 |
| Cuomo, K | 1 |
| Russell, SD | 2 |
| Cheuvront, SN | 1 |
| Kenefick, RW | 1 |
| Charkoudian, N | 1 |
| Mitchell, KM | 1 |
| Luippold, AJ | 1 |
| Bradbury, KE | 1 |
| Vidyasagar, S | 1 |
| Kiernan, MS | 1 |
| Stevens, SR | 1 |
| Butler, J | 3 |
| Anstrom, KJ | 3 |
| Birati, EY | 1 |
| Grodin, JL | 1 |
| Gupta, D | 1 |
| Margulies, KB | 1 |
| LaRue, S | 1 |
| Dávila-Román, VG | 1 |
| Hernandez, AF | 5 |
| de Las Fuentes, L | 1 |
| Ward, MJ | 1 |
| Collins, SP | 1 |
| Liu, D | 1 |
| Froehle, CM | 1 |
| Verbrugge, FH | 2 |
| Kuriyama, A | 1 |
| Urushidani, S | 1 |
| Sharma, K | 1 |
| Vaishnav, J | 1 |
| Kalathiya, R | 1 |
| Hu, JR | 1 |
| Miller, J | 1 |
| Shah, N | 1 |
| Hill, T | 1 |
| Sharp, M | 1 |
| Tsao, A | 1 |
| Alexander, KM | 1 |
| Gupta, R | 1 |
| Montemayor, K | 1 |
| Kovell, L | 1 |
| Chasler, JE | 1 |
| Lee, YJ | 1 |
| Fine, DM | 1 |
| Kass, DA | 1 |
| Weiss, RG | 1 |
| Thiemann, DR | 1 |
| Ndumele, CE | 1 |
| Schulman, SP | 1 |
| Gebreyesus, LG | 1 |
| Aregay, AF | 1 |
| Gebrekidan, KG | 1 |
| Alemayehu, YH | 1 |
| Kondo, T | 3 |
| Shiraishi, A | 2 |
| Murohara, T | 1 |
| Afari, ME | 1 |
| Aoun, J | 1 |
| Khare, S | 1 |
| Tsao, L | 1 |
| Omar, HR | 1 |
| Guglin, M | 1 |
| Dos Reis, D | 1 |
| Fraticelli, L | 1 |
| Bassand, A | 1 |
| Manzo-Silberman, S | 1 |
| Peschanski, N | 1 |
| Charpentier, S | 1 |
| Elbaz, M | 1 |
| Savary, D | 1 |
| Bonnefoy-Cudraz, E | 1 |
| Henry, P | 1 |
| Guerraoui, A | 1 |
| Tazarourte, K | 1 |
| El Khoury, C | 1 |
| Biegus, J | 1 |
| Zymlinski, R | 1 |
| Siwolowski, P | 1 |
| Testani, J | 1 |
| Szachniewicz, J | 1 |
| Tycińska, A | 1 |
| Banasiak, W | 1 |
| Halpert, A | 1 |
| Levin, H | 1 |
| Ponikowski, P | 5 |
| Ng, TM | 1 |
| Konopka, E | 1 |
| Hyderi, AF | 1 |
| Hshieh, S | 1 |
| Tsuji, Y | 1 |
| Kim, BJ | 1 |
| Han, SY | 1 |
| Phan, DH | 1 |
| Jeng, AI | 1 |
| Lou, M | 1 |
| Elkayam, U | 1 |
| Ternacle, J | 2 |
| Cognet, T | 1 |
| Gueret, P | 2 |
| Teiger, E | 1 |
| Valero, A | 1 |
| Alonso, H | 1 |
| Pérez-Durá, MJ | 1 |
| Noval, A | 1 |
| Gil-Román, JJ | 1 |
| Zapater, P | 1 |
| Llanos, L | 1 |
| Perelló, R | 1 |
| Santos, M | 2 |
| Almeida, S | 2 |
| Marques, I | 2 |
| Carvalho, H | 2 |
| Mekontso-Dessap, A | 1 |
| Meyer, G | 1 |
| Maitre, B | 1 |
| Bensaid, A | 1 |
| Jurzak, P | 1 |
| Dubois Randé, JL | 1 |
| Suzuki, M | 3 |
| Nagahori, W | 2 |
| Onishi, Y | 1 |
| Satoh, Y | 1 |
| Ono, Y | 2 |
| Nishioka, T | 1 |
| Noda, M | 1 |
| Sugi, K | 1 |
| Torii, S | 1 |
| Tejima, T | 1 |
| Sakurada, H | 1 |
| Yamaguchi, S | 1 |
| Okishige, K | 1 |
| Fujii, H | 1 |
| Takahashi, A | 1 |
| Runkle, I | 1 |
| Villabona, C | 1 |
| Navarro, A | 1 |
| Pose, A | 1 |
| Formiga, F | 3 |
| Tejedor, A | 1 |
| Poch, E | 1 |
| Tarvasmäki, T | 1 |
| Tolonen, J | 1 |
| Siirilä-Waris, K | 1 |
| Nieminen, MS | 1 |
| Lassus, J | 2 |
| Wu, MY | 1 |
| Chang, NC | 1 |
| Su, CL | 1 |
| Hsu, YH | 1 |
| Chen, TW | 1 |
| Lin, YF | 1 |
| Wu, CH | 1 |
| Tam, KW | 1 |
| Okuhara, Y | 2 |
| Hirotani, S | 2 |
| Naito, Y | 2 |
| Nakabo, A | 1 |
| Iwasaku, T | 1 |
| Eguchi, A | 1 |
| Morisawa, D | 1 |
| Ando, T | 2 |
| Sawada, H | 1 |
| Manabe, E | 1 |
| Masuyama, T | 2 |
| Valente, MA | 4 |
| Van Veldhuisen, DJ | 3 |
| Massie, BM | 1 |
| O'Connor, CM | 8 |
| Teerlink, JR | 4 |
| Cotter, G | 5 |
| Davison, B | 3 |
| Cleland, JG | 3 |
| Givertz, MM | 5 |
| Bloomfield, DM | 3 |
| Fiuzat, M | 1 |
| Dittrich, HC | 2 |
| Hillege, HL | 3 |
| Gandhi, S | 1 |
| Mosleh, W | 1 |
| Myers, RB | 1 |
| Singh, D | 1 |
| Shrestha, K | 1 |
| Dupont, M | 1 |
| Tang, WH | 3 |
| Tchernodrinski, S | 1 |
| Lucas, BP | 1 |
| Athavale, A | 1 |
| Candotti, C | 1 |
| Margeta, B | 1 |
| Katz, A | 1 |
| Kumapley, R | 1 |
| Trullàs, JC | 2 |
| Morales-Rull, JL | 2 |
| Pellegrini, M | 2 |
| Franci, B | 1 |
| Beltrami, M | 1 |
| Gonnelli, S | 1 |
| Angelini, GD | 1 |
| Nikolaev, AIu | 1 |
| Zakharova, EV | 1 |
| Tareeva, AB | 1 |
| Davison, BA | 1 |
| Felker, GM | 4 |
| Greenberg, BH | 1 |
| Pang, PS | 1 |
| Levin, B | 1 |
| Hua, TA | 1 |
| Severin, T | 1 |
| De Vecchis, R | 1 |
| Baldi, C | 1 |
| Di Biase, G | 1 |
| Castellanos, D | 1 |
| Travelli, FC | 1 |
| Reyhan, I | 1 |
| Votava-Smith, JK | 1 |
| Ramanathan, A | 1 |
| Bar-Cohen, Y | 1 |
| Wang, W | 1 |
| Liu, H | 1 |
| Yang, J | 1 |
| Shen, Y | 1 |
| Yayla, Ç | 1 |
| Akyel, A | 1 |
| Canpolat, U | 1 |
| Gayretli Yayla, K | 1 |
| Eyiol, A | 1 |
| Akboğa, MK | 1 |
| Türkoğlu, S | 1 |
| Tavil, Y | 1 |
| Boyacı, B | 1 |
| Çengel, A | 1 |
| Antoniou, CK | 1 |
| Chrysohoou, C | 1 |
| Lerakis, S | 1 |
| Manolakou, P | 1 |
| Pitsavos, C | 1 |
| Tsioufis, K | 1 |
| Stefanadis, C | 1 |
| Tousoulis, D | 1 |
| ter Maaten, JM | 3 |
| Bruno, N | 1 |
| Dunning, AM | 1 |
| Ezekowitz, JA | 2 |
| Califf, RM | 1 |
| Starling, RC | 2 |
| van der Meer, P | 2 |
| Schulte, PJ | 2 |
| Zepeda, P | 1 |
| Rain, C | 1 |
| Sepúlveda, P | 1 |
| Vaduganathan, M | 1 |
| Kumar, V | 1 |
| Sriganesh, K | 1 |
| Vimala, S | 1 |
| Venkataramaiah, S | 1 |
| Kimura, K | 1 |
| Momose, T | 1 |
| Hasegawa, T | 1 |
| Morita, T | 1 |
| Misawa, T | 1 |
| Motoki, H | 1 |
| Izawa, A | 1 |
| Ikeda, U | 1 |
| Mentz, RJ | 1 |
| Hasselblad, V | 1 |
| DeVore, AD | 1 |
| Armstrong, PW | 1 |
| Velazquez, EJ | 2 |
| Kume, T | 1 |
| Okura, H | 1 |
| Matsumura, A | 2 |
| Hashimoto, Y | 2 |
| AlFaleh, H | 1 |
| Elasfar, AA | 1 |
| Ullah, A | 1 |
| AlHabib, KF | 1 |
| Hersi, A | 1 |
| Mimish, L | 1 |
| Almasood, A | 1 |
| Al Ghamdi, S | 1 |
| Ghabashi, A | 1 |
| Malik, A | 1 |
| Hussein, GA | 1 |
| Al-Murayeh, M | 1 |
| Abuosa, A | 1 |
| Al Habeeb, W | 1 |
| Kashour, T | 1 |
| Filippatos, TD | 1 |
| Liamis, G | 1 |
| Elisaf, MS | 1 |
| Kalužay, J | 1 |
| Pokorná, V | 1 |
| Bodíková, S | 1 |
| Vahančíková, N | 1 |
| Ponťuch, P | 1 |
| Subacius, H | 1 |
| Gheorghiade, M | 1 |
| Nishimura, K | 1 |
| Orihara, Y | 1 |
| Komamura, K | 1 |
| Mano, T | 1 |
| Boundaoui, ON | 1 |
| Woodruff, TE | 1 |
| Ekmekçi, A | 1 |
| Keskin, M | 1 |
| Güvenç, TS | 1 |
| Uluganyan, M | 1 |
| Karaca, G | 1 |
| Hayıroğlu, Mİ | 1 |
| Ağustos, SŞ | 1 |
| Eren, M | 1 |
| Ronco, C | 1 |
| Wen, S | 1 |
| Ning, J | 1 |
| Collins, S | 1 |
| Berry, D | 1 |
| Jalaba, S | 1 |
| Palermo, J | 1 |
| Budavari, AI | 1 |
| Russell, NJ | 1 |
| Irwin, PJ | 1 |
| Hopper, BJ | 1 |
| Olivry, T | 1 |
| Nicholls, PK | 1 |
| Parrinello, G | 1 |
| Torres, D | 1 |
| Paterna, S | 1 |
| di Pasquale, P | 1 |
| Licata, G | 1 |
| Goebel, JA | 1 |
| Van Bakel, AB | 2 |
| Bosomworth, J | 1 |
| Dunne, C | 1 |
| Meriano, A | 1 |
| Lobo-Vielma, L | 1 |
| Colmenarez-Mendoza, H | 1 |
| Donis, JH | 1 |
| Sanchez, F | 1 |
| Perez, A | 1 |
| Villarroel, V | 1 |
| Dávila, DF | 1 |
| Ng Kam Chuen, MJ | 1 |
| Lip, GY | 1 |
| Macfadyen, RJ | 1 |
| Thomson, MR | 1 |
| Nappi, JM | 1 |
| Dunn, SP | 1 |
| Hollis, IB | 1 |
| Rodgers, JE | 1 |
| Gibney, RT | 1 |
| Goutal, CM | 1 |
| Keir, I | 1 |
| Kenney, S | 1 |
| Rush, JE | 1 |
| Freeman, LM | 1 |
| Wang, J | 2 |
| Chen, Y | 1 |
| Dong, Y | 1 |
| Hu, W | 1 |
| Zhou, P | 1 |
| Chang, L | 1 |
| Feng, S | 1 |
| Lin, J | 1 |
| Zhao, Y | 1 |
| Giamouzis, G | 1 |
| Karayannis, G | 1 |
| Nastas, J | 1 |
| Parisis, C | 1 |
| Rovithis, D | 1 |
| Economou, D | 1 |
| Savvatis, K | 1 |
| Kirlidis, T | 1 |
| Tsaknakis, T | 1 |
| Skoularigis, J | 1 |
| Westermann, D | 1 |
| Tschöpe, C | 1 |
| Triposkiadis, F | 1 |
| Maxwell, BG | 1 |
| Mihm, FG | 1 |
| Lee, KL | 2 |
| Bull, DA | 1 |
| Redfield, MM | 2 |
| Stevenson, LW | 1 |
| Goldsmith, SR | 1 |
| LeWinter, MM | 1 |
| Deswal, A | 1 |
| Rouleau, JL | 1 |
| Ofili, EO | 1 |
| McNulty, SE | 2 |
| Kfoury, AG | 1 |
| Chen, HH | 2 |
| Semigran, MJ | 1 |
| Bart, BA | 1 |
| Mascette, AM | 1 |
| Braunwald, E | 3 |
| Fonarow, GC | 2 |
| Jenkins, PG | 1 |
| Arriola-Villalobos, P | 1 |
| Iglesias-Lodares, I | 1 |
| Díaz-Valle, D | 1 |
| Garcia-Gil-de-Bernabé, J | 1 |
| Yilmaz, MB | 1 |
| Gayat, E | 1 |
| Salem, R | 1 |
| Nikolaou, M | 1 |
| Parissis, J | 1 |
| Follath, F | 1 |
| Vuylsteke, A | 1 |
| Vincent, JL | 1 |
| de La Garanderie, DP | 1 |
| Anderson, FA | 1 |
| Emery, L | 1 |
| Wyman, A | 1 |
| Rushton-Smith, S | 1 |
| Gore, JM | 1 |
| Amer, M | 1 |
| Adomaityte, J | 1 |
| Qayyum, R | 1 |
| Gotsman, I | 1 |
| Keren, A | 1 |
| Admon, D | 1 |
| Newton, PJ | 1 |
| Davidson, PM | 1 |
| Krum, H | 1 |
| Ollerton, R | 1 |
| Macdonald, P | 1 |
| Campbell, PT | 1 |
| Ryan, J | 1 |
| Núñez, E | 1 |
| Merlos, P | 1 |
| Grayson, S | 1 |
| Gandy, WE | 1 |
| Zieleskiewicz, L | 1 |
| Lagier, D | 1 |
| Contargyris, C | 1 |
| Bourgoin, A | 1 |
| Gavage, L | 1 |
| Martin, C | 1 |
| Leone, M | 1 |
| Toft, P | 1 |
| Seya, M | 1 |
| Iwatsuka, R | 1 |
| Mizukami, A | 1 |
| Ohno, M | 1 |
| Shah, RV | 1 |
| McNulty, S | 1 |
| Kociol, RD | 1 |
| Tracy, RP | 1 |
| Murcia, J | 1 |
| Reus, S | 1 |
| Climent, V | 1 |
| Manso, MI | 1 |
| López, I | 1 |
| Tello, A | 1 |
| Watanabe, T | 1 |
| Nitta, K | 1 |
| Schilling, S | 1 |
| Härtel, C | 1 |
| Gehl, HB | 1 |
| Sperner, J | 1 |
| Kula, S | 1 |
| Saygili, A | 1 |
| Tunaoğlu, FS | 1 |
| Olguntürk, R | 1 |
| Jeron, A | 1 |
| Graham, CA | 1 |
| Heidenreich, S | 1 |
| Nakagawa, NK | 1 |
| Donato-Júnior, F | 1 |
| Kondo, CS | 1 |
| King, M | 1 |
| Auler-Júnior, JO | 1 |
| Saldiva, PH | 1 |
| Lorenzi-Filho, G | 1 |
| Rinaldi, S | 1 |
| Yen, ZS | 1 |
| Chen, SC | 1 |
| Hsu, YJ | 1 |
| Chiu, JS | 1 |
| Lu, KC | 1 |
| Chau, T | 1 |
| Lin, SH | 1 |
| Aravindan, N | 1 |
| Shaw, A | 1 |
| Hodt, A | 1 |
| Steine, K | 1 |
| Atar, D | 1 |
| Francis, G | 1 |
| Xie, HH | 1 |
| Zhang, WB | 1 |
| Tian, YY | 1 |
| Li, H | 1 |
| Gu, SZ | 1 |
| Broujerdi, JA | 1 |
| Keifa, E | 1 |
| Nekhendzy, V | 1 |
| Schendel, SA | 1 |
| Biçer, S | 1 |
| Soysal, DD | 1 |
| Ctak, A | 1 |
| Uçsel, R | 1 |
| Karaböcüoğlu, M | 1 |
| Uzel, N | 1 |
| Smithline, HA | 1 |
| Rogers, HL | 1 |
| Marshall, J | 1 |
| Bock, J | 1 |
| Dowling, TC | 1 |
| Feller, E | 1 |
| Robinson, S | 1 |
| Gottlieb, SS | 1 |
| Martin, FL | 1 |
| Cataliotti, A | 1 |
| Burnett, JC | 2 |
| Romano, E | 2 |
| Gullo, A | 2 |
| Nelson, GI | 1 |
| Silke, B | 1 |
| Ahuja, RC | 1 |
| Hussain, M | 1 |
| Taylor, SH | 1 |
| Zwierzina, WD | 1 |
| Kunz, F | 1 |
| Judmaier, G | 1 |
| Mikuz, G | 1 |
| Gattringer, K | 1 |
| Veress, AT | 1 |
| Sonnenberg, H | 1 |
| Mori, K | 1 |
| Kanaya, H | 1 |
| Kon-i, I | 1 |
| Onoe, T | 1 |
| Ohka, T | 1 |
| Sato, T | 1 |
| Morimoto, S | 1 |
| Takeda, R | 1 |
| Nesterenko, IuA | 1 |
| Gol'dberg, AP | 1 |
| Laptev, VV | 2 |
| Lindenberg, AA | 1 |
| Parfrey, PS | 1 |
| Ikeman, R | 1 |
| Anglin, D | 1 |
| Cole, C | 1 |
| Berlot, G | 1 |
| Vacri, A | 1 |
| Fasiolo, S | 1 |
| Outwater, KM | 1 |
| Crone, RK | 1 |
| Dadaev, KhA | 1 |
| Jahnsen, T | 1 |
| Skovborg, F | 1 |
| Hansen, F | 1 |
| Larsen, J | 1 |
| Nordin, H | 1 |
| Storm, T | 1 |
| Levy, M | 1 |
| Finestone, H | 1 |
| Fechner, C | 1 |
| Tsygankov, BD | 1 |
| Rudoph, W | 1 |
| Dirschinger, J | 1 |
| Misiuk, NS | 1 |
| Kurgaev, VI | 1 |
| Fanucchi, MP | 1 |
| Arlin, ZA | 1 |
| Hockings, BE | 1 |
| Cope, GD | 1 |
| Clarke, GM | 1 |
| Taylor, RR | 1 |
| Lewy, JE | 3 |
| Dukov, LG | 1 |
| Pierrot, M | 1 |
| Blaise, M | 1 |
| Pourriat, JL | 1 |
| Rathat, C | 1 |
| Cupa, M | 1 |
| Espí, F | 1 |
| Fernández, MI | 1 |
| Tebar, J | 1 |
| Soriano, J | 1 |
| Ascaso, JF | 1 |
| Carmena, R | 1 |
| Lindeman, RD | 1 |
| Klingler, EL | 1 |
| Shell, W | 1 |
| Peter, T | 1 |
| Mickle, D | 1 |
| Forrester, JS | 2 |
| Swan, HJ | 1 |
| Pongpanich, B | 1 |
| Na Ayuthya, PS | 1 |
| Kantariia, VA | 1 |
| Dombrovskaia, AE | 1 |
| Shortanova, TKh | 1 |
| Gabriel, S | 1 |
| Ekelund, LG | 1 |
| Orö, L | 1 |
| Marin, I | 1 |
| Montoya-Cabrera, MA | 1 |
| Sánchez-Suárez, BA | 1 |
| Hernández-Zamora, A | 1 |
| Murguia-Chavez, LM | 1 |
| Lankisch, PG | 1 |
| Dröge, M | 1 |
| Gottesleben, F | 1 |
| Miller, M | 1 |
| Karpel, JP | 1 |
| Dworkin, F | 1 |
| Hager, D | 1 |
| Feliciano, S | 1 |
| Shapiro, D | 1 |
| Posner, L | 1 |
| Luks, D | 1 |
| Fett, DL | 1 |
| Cavero, PG | 1 |
| Marcos Sánchez, F | 1 |
| Moreno Palomares, M | 1 |
| Reinoso Cobo, D | 1 |
| Durán Pérez-Navarro, A | 1 |
| Frustaci, A | 1 |
| Gentiloni, N | 1 |
| Caldarulo, M | 1 |
| Chvilicek, JP | 1 |
| Hurlbert, BJ | 1 |
| Hill, GE | 1 |
| Northridge, D | 1 |
| Hamilton, RJ | 1 |
| Carter, WA | 1 |
| Gallagher, EJ | 1 |
| Tanigaki, T | 2 |
| Hayashi, Y | 1 |
| Katoh, H | 1 |
| Kamio, K | 1 |
| Urano, T | 1 |
| Ohta, Y | 2 |
| Frick, T | 1 |
| Lauriat, SM | 1 |
| Berl, T | 1 |
| Gammage, M | 1 |
| Metzkor, E | 1 |
| Kaluski, E | 1 |
| Faigenberg, Z | 1 |
| Miller, R | 1 |
| Simovitz, A | 1 |
| Shaham, O | 1 |
| Marghitay, D | 1 |
| Koren, M | 1 |
| Blatt, A | 1 |
| Moshkovitz, Y | 1 |
| Zaidenstein, R | 1 |
| Golik, A | 1 |
| Demircin, G | 1 |
| Oner, A | 1 |
| Tinaztepe, K | 1 |
| Bülbül, M | 1 |
| Demiriz, M | 1 |
| Erdoğan, O | 1 |
| Herfel, R | 1 |
| Stone, CK | 1 |
| Koury, SI | 1 |
| Blake, JJ | 1 |
| Missouris, CG | 1 |
| Grouzmann, E | 1 |
| Buckley, MG | 1 |
| Barron, J | 1 |
| MacGregor, GA | 1 |
| Singer, DR | 1 |
| Beltrame, JF | 1 |
| Zeitz, CJ | 1 |
| Unger, SA | 1 |
| Brennan, RJ | 1 |
| Hunt, A | 1 |
| Moran, JL | 1 |
| Horowitz, JD | 1 |
| Erstad, BL | 1 |
| Lee, EY | 1 |
| Maguire, JH | 1 |
| Werdan, K | 1 |
| Parissis, JT | 1 |
| Venetsanou, KF | 1 |
| Mentzikof, DG | 1 |
| Ziras, NG | 1 |
| Kefalas, CG | 1 |
| Karas, SM | 1 |
| Gardtman, M | 1 |
| Waagstein, L | 1 |
| Karlsson, T | 1 |
| Herlitz, J | 1 |
| Burnier, M | 1 |
| Monod, ML | 1 |
| Chioléro, A | 1 |
| Maillard, M | 1 |
| Nussberger, J | 1 |
| Brunner, HR | 1 |
| Sfakianakis, GN | 2 |
| Cavagnaro, F | 1 |
| Zilleruelo, G | 1 |
| Abitbol, C | 1 |
| Montane, B | 1 |
| Georgiou, M | 1 |
| Ezuddin, S | 1 |
| Mallin, W | 1 |
| Sfakianakis, E | 1 |
| Strauss, J | 1 |
| Shinohara, T | 1 |
| Yanai, H | 1 |
| Hidaka, T | 1 |
| Suzuki, K | 1 |
| Ohsuzu, F | 1 |
| Suehiro, K | 1 |
| Shimizu, J | 1 |
| Yi, GH | 1 |
| Gu, A | 1 |
| Keren, G | 1 |
| Burkhoff, D | 1 |
| Ivarsen, P | 1 |
| Greisen, J | 1 |
| Vilstrup, H | 1 |
| Bird, VG | 1 |
| Gomez-Marin, O | 1 |
| Leveillee, RJ | 1 |
| Rivas, LA | 1 |
| Amendola, MA | 1 |
| Webb, AR | 1 |
| Chapman, PJ | 1 |
| Bourke, JB | 1 |
| McIllmurray, MB | 1 |
| Mead, GM | 1 |
| Langman, MJ | 1 |
| Chatterjee, K | 2 |
| Seim, KE | 1 |
| Mueller, K | 1 |
| Godin, M | 1 |
| Fillastre, JP | 2 |
| Corcelle, P | 1 |
| Poirson, B | 1 |
| Dournovo, P | 1 |
| Duron, JJ | 1 |
| Garaix, JP | 1 |
| Swartz, C | 1 |
| Kim, KE | 1 |
| Rothwell, RP | 1 |
| Powers, SR | 1 |
| Shah, D | 1 |
| Ryon, D | 1 |
| Newell, J | 1 |
| Ralph, C | 1 |
| Scovill, W | 1 |
| Dutton, R | 1 |
| Castagnolo, B | 1 |
| De Colibus, V | 1 |
| Napolitano, L | 1 |
| Aliperta, A | 1 |
| Caldarelli, G | 1 |
| Abignente, F | 1 |
| Gimeno de Carlos, F | 1 |
| Bermejo Garcia, J | 1 |
| López-Sendón, JL | 1 |
| Eizaguirre Pérez, AJ | 1 |
| Flear, CT | 1 |
| Hilton, P | 1 |
| Popnikolov, S | 2 |
| Harbaugh, RD | 1 |
| James, HE | 1 |
| Marshall, LF | 1 |
| Shapiro, HM | 1 |
| Laurin, R | 1 |
| Figueras, J | 2 |
| Weil, MH | 3 |
| Décourt, LV | 1 |
| Bellotti, G | 1 |
| Pileggi, F | 2 |
| Galiano, N | 1 |
| Ramires, JA | 2 |
| Duraković, Z | 1 |
| Bakran, V | 1 |
| Vrhovac, B | 1 |
| Gjurasin, M | 1 |
| Henning, RJ | 1 |
| Mooi, W | 1 |
| Smith, P | 1 |
| Heath, D | 1 |
| Schenk, KE | 1 |
| Biamino, G | 1 |
| Schröder, R | 1 |
| Mason, DT | 1 |
| Amsterdam, EA | 1 |
| Miller, RR | 1 |
| Williams, DO | 1 |
| Tanphaichitr, P | 1 |
| Call, T | 1 |
| Malarkey, WB | 1 |
| Thomas, FB | 1 |
| Pruitt, AW | 1 |
| Boles, A | 1 |
| Diamond, NJ | 1 |
| Schofferman, J | 1 |
| Elliot, JW | 1 |
| Szeless, ST | 1 |
| Kleinberger, G | 1 |
| Kotzaurek, R | 1 |
| Pall, H | 1 |
| Pichler, M | 1 |
| Currie, TT | 1 |
| Carter, PH | 1 |
| Champion, WL | 1 |
| Fong, G | 1 |
| Francis, JK | 1 |
| McDonald, IH | 1 |
| Newing, RK | 1 |
| Nunn, IN | 1 |
| Sisson, RN | 1 |
| Sussex, M | 1 |
| Zacharin, RF | 1 |
| Daskalov, T | 1 |
| Panikian, G | 1 |
| Rahimtoola, SH | 1 |
| Gunnar, RM | 1 |
| Nikulin, KG | 1 |
| Kumamoto, K | 1 |
| Yamamoto, Y | 1 |
| Kawasaki, T | 1 |
| Omae, T | 1 |
| Tanaka, K | 1 |
| Strunge, P | 1 |
| Ayala, G | 1 |
| Chertow, BS | 1 |
| Shah, JH | 1 |
| Williams, GA | 1 |
| Kukreja, SC | 1 |
| Malach, M | 1 |
| Berman, N | 1 |
| Chandra, M | 1 |
| Agarwal, SS | 1 |
| Mitra, MK | 1 |
| Tandon, NN | 1 |
| Gupta, NN | 1 |
| Luzhnikov, EA | 1 |
| Petrova, LI | 1 |
| Kostomarova, LG | 1 |
| Kosarev, VA | 1 |
| Funk, C | 1 |
| Knoblauch, M | 1 |
| Naidoo, PM | 1 |
| Bradley, VE | 1 |
| Shier, MR | 1 |
| Lucas, CE | 1 |
| Rosenberg, IK | 1 |
| Madsen, EB | 1 |
| Mansur, Ade P | 1 |
| Lage, SG | 1 |
| César, LA | 1 |
| Tsanaclis, A | 1 |
| da Luz, PL | 1 |
| Pomini, G | 1 |
| Rugna, A | 1 |
| Lupia, M | 1 |
| Opocher, G | 1 |
| Gribaldo, R | 1 |
| Morsi, MR | 1 |
| Madina, EH | 1 |
| Anglo, AA | 1 |
| Soliman, AT | 1 |
| McLintic, AJ | 1 |
| Metcalfe, MJ | 1 |
| Ingram, KS | 1 |
| Dougall, JR | 1 |
| Bilezikian, JP | 1 |
| Rybak, LP | 1 |
| Whitworth, C | 1 |
| Scott, V | 1 |
| Vera, Z | 1 |
| Janzen, D | 1 |
| Desai, J | 1 |
| Delpech, N | 1 |
| Rapior, S | 1 |
| Donnadieu, P | 1 |
| Cozette, AP | 1 |
| Ortiz, JP | 1 |
| Huchard, G | 1 |
| Don, BR | 1 |
| Schambelan, M | 1 |
| Flammang, D | 1 |
| Waynberger, M | 1 |
| Chassing, A | 1 |
| Tarral, A | 1 |
| Izraeli, S | 1 |
| Rachmel, A | 1 |
| Frishberg, Y | 1 |
| Erman, A | 1 |
| Flasterstein, B | 1 |
| Nitzan, M | 1 |
| Boner, G | 1 |
| Venzano, C | 1 |
| Cordi, GC | 1 |
| Corsi, L | 1 |
| Dapelo, M | 1 |
| De Micheli, A | 1 |
| Grimaldi, GP | 1 |
| Kwon, NJ | 1 |
| Stolte, AL | 1 |
| Farina, JP | 1 |
| Broqvist, M | 1 |
| Dahlström, U | 1 |
| Karlberg, BE | 1 |
| Karlsson, E | 1 |
| Marklund, T | 1 |
| Chikanza, IC | 1 |
| Okwanga, PN | 1 |
| Abramovits-Ackerman, W | 1 |
| Sayegh-Carreño, R | 1 |
| Isturiz, R | 1 |
| Baldo, AG | 1 |
| Acquatella, H | 1 |
| Torres, J | 1 |
| Larsen, FF | 1 |
| Mogensen, L | 1 |
| Tedner, B | 1 |
| Yang, JY | 1 |
| Li, QH | 1 |
| Tian, GZ | 1 |
| Arcangeli, A | 1 |
| Cavaliere, F | 1 |
| Carducci, P | 1 |
| Proietti, R | 1 |
| Magalini, SI | 1 |
| Mohr, R | 1 |
| Müller, R | 1 |
| Wölfel, FE | 1 |
| Mousson, C | 1 |
| Justrabo, E | 1 |
| Tanter, Y | 1 |
| Chalopin, JM | 1 |
| Rifle, G | 1 |
| Earle, DP | 1 |
| Dobrilla, G | 1 |
| Felder, M | 1 |
| Chilovi, F | 1 |
| Braden, GL | 1 |
| Germain, MJ | 1 |
| Fitzgibbons, JP | 1 |
| Reutter, FW | 1 |
| Eugster, C | 1 |
| Iff, HW | 2 |
| Flenley, DC | 2 |
| Hughes, JM | 1 |
| Vetter, NJ | 1 |
| Strange, RC | 1 |
| Adams, W | 1 |
| Oliver, MF | 1 |
| Humbert, G | 1 |
| Leroy, J | 1 |
| Bauer, HJ | 1 |
| Karl, HJ | 1 |
| Korzon, M | 2 |
| Mryglodowicz, A | 2 |
| Kistler, HJ | 1 |
| Naso, F | 1 |
| Ditunno, JF | 1 |
| Berlin, BS | 1 |
| Simon, NM | 1 |
| Bovner, RN | 1 |
| Finnerty, FA | 1 |
| Wilson, R | 1 |
| Müchler, HC | 1 |
| Seedat, YK | 1 |
| Fiorentino, M | 1 |
| O'Brien, TG | 1 |
| Sweeney, DF | 1 |
| Holzgreve, H | 1 |
| Lüllmann, H | 1 |
| Schaefer, J | 1 |
| Tamphaichitr, P | 1 |
| Toochinda, P | 1 |
| Kashemsant, C | 1 |
| Hanrath, P | 1 |
| Bleifeld, W | 1 |
| Mathey, D | 1 |
| Merx, W | 1 |
| Beck, OA | 1 |
| Krämer, KD | 1 |
| Hochrein, H | 1 |
| McLean, KH | 1 |
| Wynn, A | 1 |
| Repetto, HA | 1 |
| Braudo, JL | 1 |
| Metcoff, J | 2 |
| Pohl, JE | 1 |
| Thurston, H | 1 |
| Davis, D | 1 |
| Morgan, MY | 1 |
| Yeboah, ED | 1 |
| Petrie, A | 1 |
| Pead, JL | 1 |
| Schmidt, P | 1 |
| Sólomon-Santibañez, G | 1 |
| Vargas-Rosendo, R | 1 |
| Santos-Atherton, D | 1 |
| Kjeldgaard, JM | 1 |
| Hahn, GW | 1 |
| Heckenlively, JR | 1 |
| Genton, E | 1 |
| Sjögren, A | 1 |
| Tattersfield, AE | 1 |
| McNicol, MW | 1 |
| Barac, G | 1 |
| Zech, P | 1 |
| Fries, D | 1 |
| Pozet, N | 1 |
| Traeger, J | 1 |
| Fritz, KW | 1 |
| Wilbrandt, R | 1 |
| Neuhaus, G | 1 |
| Schmidtmann, W | 1 |
| Wolf, CJ | 1 |
| Knott, DH | 1 |
| Beard, JD | 1 |
| Singh, I | 1 |
| Khanna, PK | 1 |
| Srivastava, MC | 1 |
| Lal, M | 1 |
| Roy, SB | 1 |
| Subramanyam, CS | 1 |
| Repetto, H | 1 |
| El-Shemy, HA | 1 |
| Aboul-Enein, AM | 1 |
| Aboul-Enein, MI | 1 |
| Issa, SI | 1 |
| Fujita, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Diuretic Versus Placebo in Pulmonary Embolism With Right Ventricular Enlargement: a Double-blind Randomized Controlled Study[NCT02268903] | Phase 3 | 270 participants (Anticipated) | Interventional | 2015-04-13 | Recruiting | ||
| Comparing a Diuretic Vascular Filling in the Initial Management of Acute Pulmonary Embolism With Right Ventricular Dysfunction Normotensive[NCT02531581] | Phase 4 | 60 participants (Actual) | Interventional | 2015-12-23 | Completed | ||
| Early and Comprehensive Care Bundle in Elderly for Acute Heart Failure: a Stepped Wedge Cluster Randomized Trial[NCT03683212] | 503 participants (Actual) | Interventional | 2018-12-10 | Completed | |||
| Effect of Short-Term Prednisone Therapy on C-reactive Protein Change in Emergency Department Patients With Acute Heart Failure and Elevated Inflammatory Markers[NCT05916586] | 120 participants (Anticipated) | Interventional | 2023-08-11 | Recruiting | |||
| Outgoing Lung Team - a Cross-sectorial and Preventive Intervention in Patients at Risk of Hospitalisation Due to Exacerbation of COPD[NCT04119856] | 144 participants (Actual) | Interventional | 2017-09-25 | Completed | |||
| A Phase II Randomized Blinded Controlled Trial of the Effect of furoSemide in Critically Ill Patients With eARly Acute Kidney Injury (The SPARK Study)[NCT00978354] | Phase 2/Phase 3 | 72 participants (Actual) | Interventional | 2009-09-30 | Terminated (stopped due to Feasibility of target enrollment within the context of available funding resources.) | ||
| Continuous Versus Bolus Intermittent Loop Diuretic Infusion in Acutely Decompensated Heart Failure: Evaluation of Renal Function, Congestion Signs, BNP and Outcome[NCT02638142] | 116 participants (Actual) | Observational | 2015-12-31 | Active, not recruiting | |||
| Prospective, Randomized, Parallel-Group Pilot Study Comparing IV Furosemide to Subcutaneous Furosemide in Acute Decompensated Heart Failure Patients[NCT02579057] | Phase 2/Phase 3 | 40 participants (Actual) | Interventional | 2016-02-29 | Completed | ||
| Randomized Evaluation of Heart Failure With Preserved Ejection Fraction (HFpEF) Patients With Acute Heart Failure and Dopamine (ROPA-DOP) Trial[NCT01901809] | Phase 4 | 90 participants (Actual) | Interventional | 2013-08-31 | Completed | ||
| Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Egyptian Cirrhotic Patients With Ascites[NCT04785755] | Phase 2 | 90 participants (Actual) | Interventional | 2017-11-30 | Completed | ||
| Oral Sodium to Preserve Renal EfficiencY in Acute Heart Failure (OSPREY-AHF)[NCT04334668] | 70 participants (Actual) | Interventional | 2020-05-20 | Active, not recruiting | |||
| A Randomized, Open-label Study of Dapagliflozin in Patients With or Without Type 2 Diabetes Admitted With Acute Heart Failure[NCT04298229] | Phase 3 | 240 participants (Actual) | Interventional | 2020-04-01 | Completed | ||
| Monitoring Patients With Acute Dyspnea With Serial Focused Ultrasound of the Heart and the Lungs[NCT04091334] | 206 participants (Actual) | Interventional | 2019-10-09 | Completed | |||
| Safety and Efficacy of the Combination of Loop Diuretics With Thiazide-type Diuretics in Patients With Decompensated Heart Failure: a Double-blind, Randomized, Placebo-controlled Trial (CLOROTIC Trial).[NCT01647932] | Phase 3 | 232 participants (Actual) | Interventional | 2014-10-31 | Completed | ||
| Continuous Versus Intermittent Loop Diuretics Infusion Dosing in Acute Heart Failure: Effects on Renal Function, Outcome and BNP Levels[NCT01441245] | Phase 4 | 57 participants (Actual) | Interventional | 2010-04-30 | Completed | ||
| A Phase II/III, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Relaxin in Subjects With Acute Heart Failure[NCT00520806] | Phase 2/Phase 3 | 1,161 participants (Actual) | Interventional | 2007-10-31 | Completed | ||
| Impact of Sodium-glucose Cotransporter Type 2 Inhibitors on the Course of Cardiorenal Syndrome in Acute Decompensation of Chronic Heart Failure[NCT04778787] | Phase 4 | 370 participants (Actual) | Interventional | 2021-01-01 | Completed | ||
| Protocol 156-03-236: Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long Term Efficacy and Safety of Oral Tolvaptan Tablets in Subjects Hospitalized With Worsening Congestive Heart Failure[NCT00071331] | Phase 3 | 3,600 participants | Interventional | 2003-09-30 | Completed | ||
| A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Effects of KW-3902 Injectable Emulsion on Heart Failure Signs and Symptoms and Renal Function in Subjects With Acute Heart Failure Syndrome and Renal Impairment Who Are Hospitalized [NCT00354458] | Phase 3 | 1,102 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
| "Early and Late Timing Indication for Starting Renal Replacement Therapy in Acute Renal Failure After Cardiac Surgery: a Prospective, Controlled, Interventional, Single-center Trial"[NCT01961999] | 1,800 participants (Actual) | Interventional | 2011-07-31 | Completed | |||
| Phase III Study of Furosemide Continuous Infusion Versus Ethacrynic Acid Continuous Infusion in Children Undergoing Cardiac Surgery: Randomized Double Blind Controlled Clinical Trial[NCT01628731] | Phase 3 | 74 participants (Actual) | Interventional | 2012-10-31 | Completed | ||
| Comparison of High-dose Furosemide Versus the Combination of Low-dose Furosemide and Low-dose Dopamine in Patients With Acute Decompensated Heart Failure[NCT00937092] | Phase 4 | 300 participants (Anticipated) | Interventional | 2009-01-31 | Recruiting | ||
| Diuretic Optimal Strategy Evaluation in Acute Heart Failure (The DOSE-AHF Study)[NCT00577135] | Phase 3 | 308 participants (Actual) | Interventional | 2008-02-29 | Completed | ||
| Efficacy and Tolerability of Combination Intravenous Diuretic Therapy Versus Intravenous Loop Diuretic Therapy Alone for the Treatment of Acute Decompensated Heart Failure[NCT05840536] | Phase 4 | 0 participants (Actual) | Interventional | 2014-05-31 | Withdrawn | ||
| High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure[NCT02429388] | Phase 4 | 0 participants (Actual) | Interventional | 2014-05-31 | Withdrawn (stopped due to Principal Investigator left institution prior to subjects being enrolled) | ||
| Remote Dielectric Sensing (ReDS) for a SAFE Discharge in Patients With Acutely Decompensated Heart Failure: The ReDS-SAFE HF Study[NCT04305717] | 240 participants (Anticipated) | Interventional | 2020-08-14 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The volume of urine produced in milliliters over the 6 hours after drug delivery will be measured. (NCT02579057)
Timeframe: 6-hour period
| Intervention | mL (Mean) |
|---|---|
| Furosemide IV | 1636 |
| Furosemide SC | 1515 |
Total urinary sodium produced during the 6 hour urine collection (NCT02579057)
Timeframe: 6-hour period
| Intervention | mEq/L (Mean) |
|---|---|
| Furosemide IV | 7.3 |
| Furosemide SC | 32.8 |
Cumulative total of pain, local skin reactions (including hematoma and induration) and electrolyte abnormalities. (NCT02579057)
Timeframe: Up to 6 hours
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| Hypokalemia | Skin irritation | Infusion site pain | |
| Furosemide IV | 0 | 0 | 0 |
| Furosemide SC | 1 | 0 | 0 |
Percent change in serum creatinine from randomization to 72 hrs from treatment protocol initiation by diuretic strategy (NCT01901809)
Timeframe: 72 hours
| Intervention | percent change in serum creatinine (Mean) |
|---|---|
| Bolus Furosemide | 4.6 |
| Continuous Infusion Furosemide | 16 |
Percent change in serum creatinine from randomization to 72 hrs from treatment protocol initiation by dopamine strategy (NCT01901809)
Timeframe: 72 hours
| Intervention | percent change in serum creatinine (Mean) |
|---|---|
| Dopamine | 8.0 |
| No Dopamine | 12.8 |
Percent change in serum creatinine from randomization to 72 hrs from treatment protocol initiation. (NCT01901809)
Timeframe: 72 hours
| Intervention | percent change in serum creatinine (Mean) |
|---|---|
| Bolus Furosemide and no Dopamine | 4 |
| Continuous Infusion Furosemide and no Dopamine | 11 |
| Bolus Furosemide Plus Dopamine | 5 |
| Continuous Furosemide Plus Dopamine | 20 |
(NCT01441245)
Timeframe: participants were followed for the duration of hospital stay, an average of 13 days
| Intervention | pg/mL (Mean) |
|---|---|
| BNP Change in cIV | -525 |
| BNP Change in iIV | -148 |
(NCT01441245)
Timeframe: in-hospital
| Intervention | percentage of partecipants (Number) |
|---|---|
| Dopamine Infusion in cIV | 50 |
| Dopamine Infusion in iIV | 26 |
(NCT01441245)
Timeframe: from admission to discharge, an average of 12 days
| Intervention | pg/ml (Mean) |
|---|---|
| BNP Levels at Discharge in cIV Group | 679 |
| BNP Levels at Discharge in iIV Group | 949 |
this study aimed to evaluate the effects of continuous infusion of furosemide in comparison to twice daily regimens at similar doses with respect to changes in renal function in terms of creatinine levels and GFR, urine output and BNP levels from admission to discharge (NCT01441245)
Timeframe: time period ranging from 72 h to 120 h.
| Intervention | mL (Mean) |
|---|---|
| Urine Output in cIV | 2505 |
| Urine Output in iIV | 2140 |
evaluation of renal function in terms of changes in creatinine levels during hospitalization in the two arms. (NCT01441245)
Timeframe: participants were followed for the duration of hospital stay, an average of 13 days
| Intervention | mg/dL (Mean) |
|---|---|
| Changes in Creatinine in cIV Group | -0.10 |
| Changes in Creatinine in iIV Group | -0.50 |
(NCT01441245)
Timeframe: from admission to discharge, an average of 12 days
| Intervention | (ml/min·1.73 m2) (Mean) |
|---|---|
| GFR Change in cIV | -3.18 |
| GFR Change in iIV | -1.93 |
(NCT01441245)
Timeframe: from admission to discharge, an average of 12 days
| Intervention | mg/dL (Mean) |
|---|---|
| Creatinine at Discharge in cIV | 1.78 |
| Creatinine at Discharge in iIV | 1.51 |
(NCT01441245)
Timeframe: from admission to discharge, an average of 12 days
| Intervention | (ml/min·1.73 m2) (Mean) |
|---|---|
| GFR at Discharge in cIV | 44.8 |
| GFR at Discharge in iIV | 46.7 |
percentage of participants with hospital stay > 10 days (NCT01441245)
Timeframe: in-hospital
| Intervention | percentage of partecipants (Number) |
|---|---|
| Lenght of Hospitalization in cIV | 80 |
| Lenght of Hospitalization in iIV | 44 |
Change in NTproBNP (NCT00577135)
Timeframe: baseline and 72 hours
| Intervention | pg/mL (Mean) |
|---|---|
| Q 12 Hour Bolus | -1316.2 |
| Continuous Infusion | -1773.2 |
| Low Intensification | -1193.8 |
| High Intensification | -1881.6 |
(NCT00577135)
Timeframe: baseline and 72 hours
| Intervention | mg/L (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.11 |
| Continuous Infusion | 0.17 |
| Low Intensification | 0.12 |
| High Intensification | 0.17 |
(NCT00577135)
Timeframe: baseline and day 60
| Intervention | mg/L (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.20 |
| Continuous Infusion | 0.16 |
| Low Intensification | 0.18 |
| High Intensification | 0.18 |
(NCT00577135)
Timeframe: baseline and day 7
| Intervention | mg/L (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.21 |
| Continuous Infusion | 0.16 |
| Low Intensification | 0.16 |
| High Intensification | 0.21 |
(NCT00577135)
Timeframe: baseline and Day 60
| Intervention | pg/mL (Mean) |
|---|---|
| Q 12 Hour Bolus | -1449.3 |
| Continuous Infusion | -1035.1 |
| Low Intensification | -1445.6 |
| High Intensification | -1038.5 |
(NCT00577135)
Timeframe: baseline and Day 7
| Intervention | pg/mL (Mean) |
|---|---|
| Q 12 Hour Bolus | -1133.3 |
| Continuous Infusion | -1552.0 |
| Low Intensification | -1037.2 |
| High Intensification | -1629.7 |
(NCT00577135)
Timeframe: baseline and 24 hours
| Intervention | mg/dL (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.00 |
| Continuous Infusion | 0.01 |
| Low Intensification | -0.01 |
| High Intensification | 0.02 |
(NCT00577135)
Timeframe: baseline and 48 hours
| Intervention | mg/dL (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.02 |
| Continuous Infusion | 0.05 |
| Low Intensification | 0.01 |
| High Intensification | 0.06 |
(NCT00577135)
Timeframe: baseline and 96 hours
| Intervention | mg/dL (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.06 |
| Continuous Infusion | 0.05 |
| Low Intensification | 0.05 |
| High Intensification | 0.07 |
(NCT00577135)
Timeframe: baseline and day 60
| Intervention | mg/dL (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.09 |
| Continuous Infusion | 0.07 |
| Low Intensification | 0.09 |
| High Intensification | 0.07 |
(NCT00577135)
Timeframe: baseline and day 7
| Intervention | mg/dL (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.10 |
| Continuous Infusion | 0.04 |
| Low Intensification | 0.07 |
| High Intensification | 0.08 |
(NCT00577135)
Timeframe: Measured at baseline and 72 hours
| Intervention | mg/dL (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.05 |
| Continuous Infusion | 0.07 |
| Low Intensification | 0.04 |
| High Intensification | 0.08 |
(NCT00577135)
Timeframe: baseline and 72 hours
| Intervention | mg/dL (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.30 |
| Continuous Infusion | 0.44 |
| Low Intensification | 0.11 |
| High Intensification | 0.61 |
(NCT00577135)
Timeframe: baseline and Day 60
| Intervention | mg/dL (Mean) |
|---|---|
| Q 12 Hour Bolus | -0.09 |
| Continuous Infusion | -0.71 |
| Low Intensification | -0.13 |
| High Intensification | -0.67 |
(NCT00577135)
Timeframe: baseline and day 7
| Intervention | mg/dL (Mean) |
|---|---|
| Q 12 Hour Bolus | 0.40 |
| Continuous Infusion | 0.09 |
| Low Intensification | 0.07 |
| High Intensification | 0.42 |
(NCT00577135)
Timeframe: baseline and 96 hours
| Intervention | lbs (Mean) |
|---|---|
| Q 12 Hour Bolus | -8.0 |
| Continuous Infusion | -9.1 |
| Low Intensification | -7.4 |
| High Intensification | -9.6 |
Dyspnea Visual Analog Scale Scale Range 0-4800; higher score is better (NCT00577135)
Timeframe: 48 hours
| Intervention | units on a scale (Mean) |
|---|---|
| Q 12 Hour Bolus | 2876.6 |
| Continuous Infusion | 3033.1 |
| Low Intensification | 2924.9 |
| High Intensification | 2981.3 |
Dyspnea Visual Analog Scale Scale Range 0-7200; higher score is better (NCT00577135)
Timeframe: 72 hours
| Intervention | units on a scale (Mean) |
|---|---|
| Q 12 Hour Bolus | 4455.6 |
| Continuous Infusion | 4699.1 |
| Low Intensification | 4477.9 |
| High Intensification | 4668.3 |
Global Visual Analog Scale Scale Range 0-2400; higher score is better (NCT00577135)
Timeframe: Measured at 24 hours
| Intervention | units on a scale (Mean) |
|---|---|
| Q 12 Hour Bolus | 1370.8 |
| Continuous Infusion | 1453.8 |
| Low Intensification | 1426.0 |
| High Intensification | 1398.2 |
(NCT00577135)
Timeframe: Through 24 hours
| Intervention | mL (Mean) |
|---|---|
| Q 12 Hour Bolus | 1595.7 |
| Continuous Infusion | 1796.4 |
| Low Intensification | 1209.7 |
| High Intensification | 2149.6 |
(NCT00577135)
Timeframe: Through 48 hours
| Intervention | mL (Mean) |
|---|---|
| Q 12 Hour Bolus | 2996.7 |
| Continuous Infusion | 3120.6 |
| Low Intensification | 2334.8 |
| High Intensification | 3747.4 |
(NCT00577135)
Timeframe: Through 72 hours
| Intervention | mL (Mean) |
|---|---|
| Q 12 Hour Bolus | 4236.7 |
| Continuous Infusion | 4249.2 |
| Low Intensification | 3575.2 |
| High Intensification | 4898.9 |
Global Visual Analog Scale Scale Range 0-2400; higher score is better (NCT00577135)
Timeframe: Measured at 24 hours
| Intervention | units on a scale (Mean) |
|---|---|
| Q 12 Hour Bolus | 1280.8 |
| Continuous Infusion | 1303.0 |
| Low Intensification | 1288.6 |
| High Intensification | 1294.8 |
Global Visual Analog Scale Scale Range 0-4800; higher score is better (NCT00577135)
Timeframe: 48 hours
| Intervention | units on a scale (Mean) |
|---|---|
| Q 12 Hour Bolus | 2722.6 |
| Continuous Infusion | 2792.6 |
| Low Intensification | 2706.5 |
| High Intensification | 2805.2 |
Global Visual Analog Scale Scale Range 0-7200; higher score is better (NCT00577135)
Timeframe: Measured at 72 hours
| Intervention | units on a scale (Mean) |
|---|---|
| Q 12 Hour Bolus | 4236 |
| Continuous Infusion | 4372.7 |
| Low Intensification | 4170.8 |
| High Intensification | 4429.6 |
(NCT00577135)
Timeframe: Within 72 hours
| Intervention | percentage of participants (Number) |
|---|---|
| Q 12 Hour Bolus | 17.4 |
| Continuous Infusion | 19.2 |
| Low Intensification | 13.6 |
| High Intensification | 22.7 |
(NCT00577135)
Timeframe: Measured at 72 hours
| Intervention | percentage of participants (Number) |
|---|---|
| Q 12 Hour Bolus | 14.4 |
| Continuous Infusion | 15.3 |
| Low Intensification | 11.2 |
| High Intensification | 18.2 |
Treatment failure is defined as the patient met cardiorenal syndrome endpoint, worsening or persistent heart failure endpoint, patient died, or there was clinical evidence of overdiuresis requiring intervention within first 72 hours after randomization (NCT00577135)
Timeframe: Within 72 hours
| Intervention | percentage of participants (Number) |
|---|---|
| Q 12 Hour Bolus | 38.1 |
| Continuous Infusion | 38.8 |
| Low Intensification | 36.7 |
| High Intensification | 40.0 |
31 reviews available for furosemide and Acute Disease
| Article | Year |
|---|---|
Continuous infusion vs. intermittent bolus injection of furosemide in acute decompensated heart failure: systematic review and meta-analysis of randomised controlled trials.
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Injections, Int | 2018 |
Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis.
Topics: Acute Disease; Aged; Aged, 80 and over; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged | 2019 |
Subcutaneous furosemide for the treatment of heart failure: a state-of-the art review.
Topics: Acute Disease; Animals; Diuretics; Dogs; Furosemide; Heart Failure; Hospice Care; Humans; Infusions, | 2019 |
Loop diuretic strategies in patients with acute decompensated heart failure: a meta-analysis of randomized controlled trials.
Topics: Acute Disease; Critical Care; Furosemide; Heart Failure; Hospital Mortality; Humans; Infusions, Intr | 2014 |
Hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis.
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans; Randomized Controlled Trials as Topic; | 2014 |
[Diuretic therapy in acute heart failure].
Topics: Acute Disease; Adsorption; Diuretics; Drug Synergism; Drug Therapy, Combination; Furosemide; Heart F | 2014 |
[Alternatives to conventional diuretic therapy in heart failure].
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardio-Renal Syndrome; Clini | 2014 |
What are the effects of hypertonic saline plus furosemide in acute heart failure?
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans; Length of Stay; Patient Readmission; Ra | 2015 |
Ten pitfalls in the proper management of patients with hyponatremia.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Chronic Disease; Diuretics; Drug Dosage Ca | 2016 |
Which dosing of furosemide is better in acute decompensated heart failure?
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans | 2017 |
Rational use of diuretics in acute decompensated heart failure.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Diuretics; Drug Resistance; Drug Therapy, | 2008 |
Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine, despite the lack of a proven survival benefit.
Topics: Acute Disease; Blood Pressure; Diuretics; Dyspnea; Furosemide; Heart Failure; Nitroglycerin; Vasodil | 2011 |
Continuous infusion versus intermittent bolus furosemide in ADHF: an updated meta-analysis of randomized control trials.
Topics: Acute Disease; Aged; Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Male; Middle | 2012 |
Diuretic dosing in acute decompensated heart failure: lessons from DOSE.
Topics: Acute Disease; Aged; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Fem | 2012 |
Acute poststreptococcal glomerulonephritis and acute rheumatic fever in the same patient: a case report and review of the literature.
Topics: Acute Disease; Adolescent; Child; Diagnosis, Differential; Echocardiography, Doppler; Female; Furose | 2003 |
Pharmacological therapy of acute cardiogenic pulmonary oedema in the emergency department.
Topics: Acute Disease; Analgesics, Opioid; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Cri | 2004 |
[The patient with edema of the legs].
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Creatinine; Diagnosis, Differential; Diuretics; Drug Th | 2004 |
Best evidence topic report. Nebulised furosemide in acute adult asthma.
Topics: Acute Disease; Adrenergic beta-Agonists; Adult; Asthma; Bronchodilator Agents; Drug Therapy, Combina | 2005 |
[Medical and ventilatory treatment of acute heart failure].
Topics: Acute Disease; Adrenergic beta-Agonists; Cardiotonic Agents; Continuous Positive Airway Pressure; Di | 2006 |
Acute decompensated heart failure: the cardiorenal syndrome.
Topics: Acute Disease; Disease Progression; Diuretics; Furosemide; Glomerular Filtration Rate; Heart Failure | 2006 |
Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators.
Topics: Acute Disease; Cyclic GMP; Diuretics; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; | 2008 |
Diuretics in infancy.
Topics: Acute Disease; Benzothiadiazines; Diet, Sodium-Restricted; Diuretics; Diuretics, Osmotic; Edema; Eth | 1981 |
The hyponatremic patient: practical focus on therapy.
Topics: Acute Disease; Blood Volume; Body Water; Brain Edema; Chronic Disease; Demyelinating Diseases; Diure | 1997 |
[Emergency treatment of acute heart failure].
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Analgesics, Opioid; Angioplasty, Balloon, Coronary | 1999 |
Management of acute heart failure.
Topics: Acute Disease; Anti-Arrhythmia Agents; Diuretics; First Aid; Furosemide; Heart Failure; Humans; Shoc | 2002 |
Pump failure in acute myocardial infarction. Fluid and drug therapy.
Topics: Acute Disease; Albumins; Dextrans; Furosemide; Glucose; Heart; Hemodynamics; Humans; Infusions, Pare | 1977 |
Digitalis in acute myocardial infarction: help or hazard?
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Depression, Chemical; | 1975 |
Management of acute hypercalcemia.
Topics: Acute Disease; Calcitonin; Diphosphonates; Fluid Therapy; Furosemide; Gallium; Humans; Hypercalcemia | 1992 |
[Treatment of the acute hypercalcemic crisis].
Topics: Acute Disease; Adrenal Cortex Hormones; Antineoplastic Agents; Calcitonin; Diet Therapy; Edetic Acid | 1973 |
Acute high-altitude illness in mountaineers and problems of rescue.
Topics: Acclimatization; Acetazolamide; Acute Disease; Altitude; Brain Edema; Coma; Dexamethasone; Furosemid | 1973 |
[Current status of brain edema therapy].
Topics: Acute Disease; Analgesics; Brain Edema; Carbon Dioxide; Ergot Alkaloids; Furosemide; Glucocorticoids | 1974 |
52 trials available for furosemide and Acute Disease
| Article | Year |
|---|---|
Diuretic vs. placebo in intermediate-risk acute pulmonary embolism: a randomized clinical trial.
Topics: Acute Disease; Diuretics; Double-Blind Method; Furosemide; Humans; Pulmonary Embolism; Treatment Out | 2022 |
Diuretics Versus Volume Expansion in the Initial Management of Acute Intermediate High-Risk Pulmonary Embolism.
Topics: Acute Disease; Biomarkers; Diuretics; Furosemide; Humans; Natriuretic Peptide, Brain; Pulmonary Embo | 2022 |
Effect of an Emergency Department Care Bundle on 30-Day Hospital Discharge and Survival Among Elderly Patients With Acute Heart Failure: The ELISABETH Randomized Clinical Trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Diuretics; Emergency Service, Hospital; Female; France; Furo | 2020 |
Effect of an Emergency Department Care Bundle on 30-Day Hospital Discharge and Survival Among Elderly Patients With Acute Heart Failure: The ELISABETH Randomized Clinical Trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Diuretics; Emergency Service, Hospital; Female; France; Furo | 2020 |
Effect of an Emergency Department Care Bundle on 30-Day Hospital Discharge and Survival Among Elderly Patients With Acute Heart Failure: The ELISABETH Randomized Clinical Trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Diuretics; Emergency Service, Hospital; Female; France; Furo | 2020 |
Effect of an Emergency Department Care Bundle on 30-Day Hospital Discharge and Survival Among Elderly Patients With Acute Heart Failure: The ELISABETH Randomized Clinical Trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Diuretics; Emergency Service, Hospital; Female; France; Furo | 2020 |
Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: Conventional vs Carbohydrate Antigen 125-guided Strategy. Clinical Trial Design.
Topics: Acetazolamide; Acute Disease; CA-125 Antigen; Cardio-Renal Syndrome; Chlorthalidone; Creatinine; Diu | 2017 |
The effect of low-dose furosemide in critically ill patients with early acute kidney injury: A pilot randomized blinded controlled trial (the SPARK study).
Topics: Acute Disease; Acute Kidney Injury; Aged; Critical Illness; Diuretics; Double-Blind Method; Female; | 2017 |
Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR-AHF.
Topics: Acute Disease; Dose-Response Relationship, Drug; Follow-Up Studies; Furosemide; Heart Failure; Human | 2017 |
Diuretics versus volume expansion in acute submassive pulmonary embolism.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Diuretics; Echocardiography, Doppler; Female; Fl | 2017 |
Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure.
Topics: Acute Disease; Diuretics; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Furosemide; H | 2018 |
Efficacy of Glucose or Amino Acid-Based Commercial Beverages in Meeting Oral Rehydration Therapy Goals After Acute Hypertonic and Isotonic Dehydration.
Topics: Acute Disease; Adolescent; Adult; Amino Acids; Beverages; Dehydration; Electrolytes; Exercise; Femal | 2018 |
Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Cystatin C; Dose-Response Relationship, Drug; Fe | 2018 |
Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial.
Topics: Acute Disease; Aged; Creatinine; Diuretics; Dopamine; Drug Therapy, Combination; Female; Furosemide; | 2018 |
Specialty-Related Differences in the Acute-Phase Treatment and Prognosis in Patients With Acute Heart Failure - Insights From REALITY-AHF.
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiologists; Disease-Free Survival; Emergency Service, Hos | 2018 |
Higher Diuretic Requirements in Acute Heart Failure With Admission Hyponatraemia Versus Normonatraemia.
Topics: Acute Disease; Adult; Aged; Diuretics; Female; Furosemide; Heart Failure; Humans; Hyponatremia; Male | 2020 |
Controlled decongestion by Reprieve therapy in acute heart failure: results of the TARGET-1 and TARGET-2 studies.
Topics: Acute Disease; Aged; Central Venous Pressure; Creatinine; Diuretics; Edema, Cardiac; Equipment and S | 2019 |
Clinical effects and safety of different strategies for administering intravenous diuretics in acutely decompensated heart failure: a randomised clinical trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Creatinine; Diuretics; Female; Furosemide; Heart | 2014 |
Clinical effectiveness of tolvaptan in patients with acute decompensated heart failure and renal failure: design and rationale of the AQUAMARINE study.
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics; Drug Therapy, Com | 2014 |
Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Chronic Disease; Disease Progression; Diuretics; Edema; Fema | 2014 |
Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Furosemide; Glomerular Fi | 2014 |
Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Furosemide; Glomerular Fi | 2014 |
Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Furosemide; Glomerular Fi | 2014 |
Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Furosemide; Glomerular Fi | 2014 |
Diuretic response in acute heart failure: clinical characteristics and prognostic significance.
Topics: Acute Disease; Aged; Analysis of Variance; Atherosclerosis; Bumetanide; Diabetes Complications; Diur | 2014 |
Short and long-term effects of continuous versus intermittent loop diuretics treatment in acute heart failure with renal dysfunction.
Topics: Acute Disease; Administration, Intravenous; Aged; Diuretics; Female; Furosemide; Heart Failure; Huma | 2015 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF.
Topics: Acute Disease; Aged; Diuretics; Double-Blind Method; Female; Furosemide; Heart Failure; Humans; Leng | 2014 |
Comparison of three diuretic treatment strategies for patients with acute decompensated heart failure.
Topics: Acute Disease; Administration, Oral; Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzym | 2015 |
Diuretic response in acute heart failure-an analysis from ASCEND-HF.
Topics: Acute Disease; Aged; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Double-Blind | 2015 |
Diuretic response in acute heart failure-an analysis from ASCEND-HF.
Topics: Acute Disease; Aged; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Double-Blind | 2015 |
Diuretic response in acute heart failure-an analysis from ASCEND-HF.
Topics: Acute Disease; Aged; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Double-Blind | 2015 |
Diuretic response in acute heart failure-an analysis from ASCEND-HF.
Topics: Acute Disease; Aged; Disease Progression; Diuretics; Dose-Response Relationship, Drug; Double-Blind | 2015 |
Early administration of tolvaptan preserves renal function in elderly patients with acute decompensated heart failure.
Topics: Acute Disease; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Diuretics | 2016 |
Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial).
Topics: Acute Disease; Aged; Cause of Death; Dose-Response Relationship, Drug; Double-Blind Method; Female; | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Combining Diuretic Response and Hemoconcentration to Predict Rehospitalization After Admission for Acute Heart Failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Biomarkers; Decision Support Techniques; Diure | 2016 |
Different diuretic dose and response in acute decompensated heart failure: Clinical characteristics and prognostic significance.
Topics: Acute Disease; Administration, Intravenous; Aged; Aged, 80 and over; Diuretics; Dose-Response Relati | 2016 |
A response-adaptive design of initial therapy for emergency department patients with heart failure.
Topics: Acute Disease; Bayes Theorem; Blood Pressure; Diuretics; Dyspnea; Emergency Service, Hospital; Furos | 2017 |
Continuous versus intermittent infusion of furosemide in acute decompensated heart failure.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Dose-Response Re | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.
Topics: Acute Disease; Adult; Alberta; Biomarkers; Critical Illness; Disease Progression; Diuretics; Female; | 2010 |
Impact of dopamine infusion on renal function in hospitalized heart failure patients: results of the Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Dopamine; Double-Blind Method; Female; Furosemide; Heart Fai | 2010 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
Diuretic strategies in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Area Under Curve; Creatinine; Diuretics; Double-Blind Method; Drug Administrati | 2011 |
The acute haemodynamic effect of nebulised frusemide in stable, advanced heart failure.
Topics: Acute Disease; Cardiac Catheterization; Diuretics; Double-Blind Method; Female; Furosemide; Heart Fa | 2012 |
Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure.
Topics: Acute Disease; Administration, Oral; Aged; Aged, 80 and over; Creatinine; Cystatin C; Diuretics; Dos | 2012 |
A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
Topics: Acute Disease; Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Edema; E | 2008 |
Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart-failure following myocardial infarction.
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Furosemide; Heart Failure; Hemodynamics; Human | 1983 |
Frusemide or isosorbide dinitrate for acute heart failure?
Topics: Acute Disease; Clinical Trials as Topic; Furosemide; Heart Failure; Hemodynamics; Humans; Infusions, | 1983 |
Randomized controlled trial of vasodilator therapy after myocardial infarction.
Topics: Acute Disease; Blood Pressure; Clinical Trials as Topic; Creatine Kinase; Female; Follow-Up Studies; | 1981 |
Inhaled furosemide is not effective in acute asthma.
Topics: Acute Disease; Administration, Inhalation; Adolescent; Adult; Analysis of Variance; Asthma; Drug The | 1994 |
Rapid improvement of acute pulmonary edema with sublingual captopril.
Topics: Acute Disease; Administration, Sublingual; Adult; Aged; Analysis of Variance; Angiotensin-Converting | 1996 |
Furosemide given by inhalation ameliorates acute exacerbation of asthma.
Topics: Acute Disease; Administration, Inhalation; Adult; Aminophylline; Anti-Asthmatic Agents; Anti-Inflamm | 1997 |
Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema.
Topics: Acute Disease; Aged; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans | 1998 |
Nitrate therapy is an alternative to furosemide/morphine therapy in the management of acute cardiogenic pulmonary edema.
Topics: Acetylcysteine; Acute Disease; Diuretics; Drug Tolerance; Female; Free Radical Scavengers; Furosemid | 1998 |
Renal sodium handling in acute and chronic salt loading/depletion protocols: the confounding influence of acute water loading.
Topics: Acute Disease; Adult; Blood Pressure; Chronic Disease; Diet, Sodium-Restricted; Diuretics; Furosemid | 2000 |
Hypertonic mannitol in the therapy of the acute respiratory distress syndrome.
Topics: Acute Disease; Adolescent; Adult; Aged; Cardiac Output; Child; Clinical Trials as Topic; Drug Evalua | 1977 |
[Clinical evaluation of the use of diuretics in the ascitic phase of hepatic cirrhosis].
Topics: Acute Disease; Adult; Aged; Amiloride; Ascites; Clinical Trials as Topic; Diuretics; Drug Evaluation | 1977 |
[Therapeutic indications in left ventricular insufficiency in acute myocardial infarct].
Topics: Acute Disease; Clinical Trials as Topic; Drug Evaluation; Fluid Therapy; Furosemide; Hemodynamics; H | 1979 |
[Haemodynamic effects of furosemide and ethacrynic acid (author's transl)].
Topics: Acute Disease; Blood Pressure; Blood Vessels; Coronary Disease; Ethacrynic Acid; Furosemide; Heart; | 1975 |
Evaluation of captopril versus reserpine and frusemide in treating hypertensive children with acute post-streptococcal glomerulonephritis.
Topics: Acute Disease; Administration, Oral; Blood Pressure; Captopril; Child; Child, Preschool; Drug Admini | 1992 |
[Intravenous enoximone versus conventional treatment in acute lung edema. Preliminary results of a randomized study].
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiotonic Agents; Dobutamine; Dopamine; Drug Therapy, Comb | 1990 |
[Efficacy of intravenous furosemide in the initial stage of poststreptococcal acute glomerulonephritis].
Topics: Acute Disease; Adolescent; Blood Pressure; Body Weight; Child; Child, Preschool; Clinical Trials as | 1971 |
Acute mountain sickness.
Topics: Acclimatization; Acute Disease; Adolescent; Adult; Altitude; Ammonium Chloride; Aspirin; Blood Flow | 1969 |
212 other studies available for furosemide and Acute Disease
| Article | Year |
|---|---|
Early drop in systolic blood pressure is associated with poor diuretic response and prognosis in patients with acute heart failure.
Topics: Acute Disease; Blood Pressure; Diuretics; Furosemide; Heart Failure; Humans; Prognosis | 2022 |
Impact of prehospital IV furosemide or nitrate application on hospital outcome in acute heart failure patients.
Topics: Acute Disease; Aged; Aged, 80 and over; Diuretics; Emergency Medical Services; Furosemide; Heart Fai | 2022 |
Door-to-furosemide time and clinical outcomes in acute heart failure.
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans; Prospective Studies | 2023 |
Tolvaptan's Association with Low Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease and Acute Decompensated Heart Failure.
Topics: Acute Disease; Acute Kidney Injury; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; F | 2023 |
Acute pancreatitis caused by tigecycline and furosemide combination treatment and hypofibrinogenemia caused by tigecycline: A case report.
Topics: Acinetobacter baumannii; Acute Disease; Afibrinogenemia; Aged; Anti-Bacterial Agents; Fibrinogen; Fu | 2023 |
Decongestion strategies in patients presenting with acutely decompensated heart failure: A worldwide survey among physicians.
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans; Physicians; Surveys and Questionnaires; | 2023 |
Outpatient Intravenous Diuretic Therapy for Acute Heart Failure: A Simplified Solution to a Formidable Problem.
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Humans; Outpatients; Sodium Potassium Chloride | 2020 |
Diabetic patients need higher furosemide doses: a report on acute and chronic heart failure patients.
Topics: Acute Disease; Aged; Aged, 80 and over; Chronic Disease; Diabetes Mellitus; Drug Resistance; Female; | 2020 |
Real World Use of Hypertonic Saline in Refractory Acute Decompensated Heart Failure: A U.S. Center's Experience.
Topics: Acute Disease; Diuretics; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Furosemide; H | 2020 |
The FAST-FURO study: effect of very early administration of intravenous furosemide in the prehospital setting to patients with acute heart failure attending the emergency department.
Topics: Acute Disease; Diuretics; Emergency Medical Services; Emergency Service, Hospital; Furosemide; Heart | 2021 |
Association of early administration of furosemide with improved oxygenation in patients with acute heart failure.
Topics: Acute Disease; Diuretics; Furosemide; Heart Failure; Hospital Mortality; Humans | 2021 |
The future of community nursing: Hospital in the Home.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Bronchodilator Agents; Clergy; Community Health Nursing; | 2017 |
Time-to-Furosemide Treatment and Mortality in Patients Hospitalized With Acute Heart Failure.
Topics: Acute Disease; Aged; Diuretics; Female; Follow-Up Studies; Furosemide; Heart Failure; Hospital Morta | 2017 |
A rare form of extremely wide QRS complex due to reversed homologous electrical ventricular separation of acute heart failure.
Topics: Acute Disease; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Benzaze | 2018 |
Preventable delays to intravenous furosemide administration in the emergency department prolong hospitalization for patients with acute heart failure.
Topics: Acute Disease; Administration, Intravenous; Aged; Diuretics; Emergency Service, Hospital; Female; Fu | 2018 |
Hyponatremia in Acute Heart Failure in Relation to Hematocrit Levels: Clinical Relevance and Prognostic Implication.
Topics: Acute Disease; Administration, Intravenous; Aged; Aged, 80 and over; Diuretics; Female; Furosemide; | 2018 |
Factors associated with treatment outcome of acute post streptococcal glomerulonephritis among patients less than 18 years in Mekelle City, Public Hospitals, North Ethiopia.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Antihypertensive Agents; Child; Child, Preschool; | 2018 |
Impact of renal dysfunction on the management and outcome of acute heart failure: results from the French prospective, multicentre, DeFSSICA survey.
Topics: Acute Disease; Aged; Aged, 80 and over; Cardio-Renal Syndrome; Comorbidity; Defibrillators; Disease | 2019 |
Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure.
Topics: Acute Disease; Adult; Aged; Blood Urea Nitrogen; Bumetanide; Cohort Studies; Diuretics; Drug Therapy | 2013 |
Should furosemide be avoided in acute right ventricular myocardial infarction?
Topics: Acute Disease; Adult; Aged; Alanine Transaminase; Biomarkers; Blood Pressure; Creatinine; Diuretics; | 2013 |
Tailoring diuretic therapy in acute heart failure: insight into early diuretic response predictors.
Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Diuretics | 2013 |
Diuretics in normotensive patients with acute pulmonary embolism and right ventricular dilatation.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Blood Pressure; Dilatation, Pathologic; Diuretics; Fe | 2013 |
[The treament of hyponatremia secundary to the syndrome of inappropriate antidiuretic hormone secretion].
Topics: Acute Disease; Algorithms; Benzazepines; Combined Modality Therapy; Decision Support Techniques; Flu | 2013 |
Management of acute heart failure and the effect of systolic blood pressure on the use of intravenous therapies.
Topics: Acute Disease; Aged; Analgesics, Opioid; Blood Pressure; Cardiotonic Agents; Chronic Disease; Diseas | 2013 |
Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure.
Topics: Acute Disease; Adult; Aged; Biomarkers; Cohort Studies; Female; Furosemide; Heart Failure; Humans; I | 2014 |
Inferior vena cava diameter change after intravenous furosemide in patients diagnosed with acute decompensated heart failure.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Cohort Studies; Diuretics; Female; Furosemide; Heart | 2015 |
[The specific features of kidney injury due to abuse of saluretics and uncontrollable fasting in anorexia nervosa].
Topics: Acute Disease; Acute Kidney Injury; Adult; Anorexia Nervosa; Diuretics; Fasting; Female; Furosemide; | 2014 |
Poor concordance between different definitions of worsening renal function in patients with acute exacerbation of chronic heart failure: a retrospective study.
Topics: Acute Disease; Administration, Intravenous; Aged; Aged, 80 and over; Chronic Disease; Creatinine; Di | 2016 |
Acute Aortic and Mitral Valve Perforations Caused by Granulomatosis With Polyangiitis.
Topics: Acute Disease; Anemia; Anti-Bacterial Agents; Aortic Valve; Child; Combined Modality Therapy; Diagno | 2015 |
Acute Pulmonary Edema After Cranioplasty.
Topics: Accidents, Traffic; Acute Disease; Anti-Inflammatory Agents; Decompressive Craniectomy; Diuretics; F | 2016 |
Effects of ventriculoarterial coupling changes on renal function, echocardiographic indices and energy efficiency in patients with acute decompensated systolic heart failure under furosemide and dopamine treatment: a comparison of three therapeutic protoc
Topics: Acute Disease; Aged; Cardiotonic Agents; Diuretics; Dopamine; Dose-Response Relationship, Drug; Drug | 2015 |
A combined clinical and biomarker approach to predict diuretic response in acute heart failure.
Topics: Acute Disease; Atherosclerosis; Biomarkers; Clinical Trials, Phase III as Topic; Diuretics; Electrol | 2016 |
Unsolved challenges in diuretic therapy for acute heart failure: a focus on diuretic response.
Topics: Acute Disease; Atherosclerosis; Diuretics; Dose-Response Relationship, Drug; Furosemide; Heart Failu | 2015 |
Acute Pulmonary Edema Following Plasma Exchange in a Patient With Guillian Barre Syndrome.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Ceftriaxone; Diuretics; Female; Furosemide; Guillain-Ba | 2017 |
Renal function on admission modifies prognostic impact of diuretics in acute heart failure: a propensity score matched and interaction analysis.
Topics: Acute Disease; Administration, Intravenous; Aged; Aged, 80 and over; Chi-Square Distribution; Diuret | 2016 |
Worsening heart failure in 'real-world' clinical practice: predictors and prognostic impact.
Topics: Acute Disease; Adrenergic beta-Antagonists; Cardiotonic Agents; Disease Progression; Diuretics; Drug | 2017 |
[Diuretic treatment in patients with acute pulmonary edema did not produces severe hyponatremia or hypokalemia].
Topics: Acute Disease; Aged; Aged, 80 and over; Diuretics; Female; Furosemide; Hospitalization; Humans; Male | 2016 |
Comparison of salt with low-dose furosemide and carperitide for treating acute decompensated heart failure: a single-center retrospective cohort study.
Topics: Acute Disease; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Costs and Cost Analysis; Diuretic | 2017 |
Presumed Furosemide-associated Bilateral Angle-Closure Glaucoma.
Topics: Acute Disease; Anterior Eye Segment; Diagnosis, Differential; Diuretics; Female; Furosemide; Glaucom | 2016 |
Usefulness of the thrombolysis in myocardial infarction risk index in acute heart failure: a pilot study.
Topics: Acute Disease; Adult; Age Factors; Blood Pressure; Blood Urea Nitrogen; C-Reactive Protein; Diuretic | 2016 |
Acute necrotising pulmonary vasculitis and pulmonary hypertension in a juvenile dog.
Topics: Acute Disease; Animals; Anti-Anxiety Agents; Dog Diseases; Dogs; Fatal Outcome; Female; Furosemide; | 2008 |
The pathophysiology of acute heart failure: the key role of fluid accumulation.
Topics: Acute Disease; Diuretics; Edema, Cardiac; Furosemide; Heart Failure; Hemodynamics; Humans | 2008 |
Rural treatment of acute cardiogenic pulmonary edema: applying the evidence to achieve success with failure.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Benzodiazepines; Captopril; Continuous Posi | 2008 |
Acute postpartum pulmonary edema in a 23-year-old woman 5 days after cesarean delivery.
Topics: Acute Disease; Central Venous Pressure; Cesarean Section; Diagnosis, Differential; Diuretics; Drug T | 2009 |
Acutely decompensated systolic heart failure: effects of frequent doses of furosemide vs a single dose plus carvedilol on clinical status, neurohormonal activation and ventricular arrhythmias.
Topics: Acute Disease; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Diuretics; Drug Administration S | 2010 |
Performing repeated noninvasive bedside measures of volume response to intravenous furosemide in acute pulmonary edema: a feasibility assessment.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Body Composition; Diuresis; Diuretics; Drug Monitorin | 2009 |
Evaluation of acute congestive heart failure in dogs and cats: 145 cases (2007-2008).
Topics: Acute Disease; Animals; Cat Diseases; Cats; Diuretics; Dog Diseases; Dogs; Female; Furosemide; Heart | 2010 |
[Role of 6% hydroxyethylstarch 130/0.4 and furosemide in the treatment of acute pancreatitis].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Furosemi | 2010 |
Questioning diuretic use in acute negative-pressure pulmonary edema.
Topics: Acute Disease; Adult; Diuretics; Furosemide; Humans; Laryngismus; Male; Postoperative Complications; | 2011 |
Comparative effectiveness of diuretic regimens.
Topics: Acute Disease; Comparative Effectiveness Research; Drug Administration Schedule; Furosemide; Heart F | 2011 |
Diuretic strategies in patients with acute heart failure.
Topics: Acute Disease; Diuretics; Drug Administration Schedule; Furosemide; Heart Failure; Humans | 2011 |
[Pupillary block acute glaucoma due to acrylic intraocular lens posterior dislocation after Nd:YAG capsulotomy].
Topics: Acute Disease; Aged; Brimonidine Tartrate; Combined Modality Therapy; Dipyrone; Drug Therapy, Combin | 2011 |
Impact of diuretic dosing on mortality in acute heart failure using a propensity-matched analysis.
Topics: Acute Disease; Dose-Response Relationship, Drug; Furosemide; Health Care Surveys; Heart Failure; Hum | 2011 |
Characteristics, practice patterns, and outcomes in patients with acute hypertension: European registry for Studying the Treatment of Acute hyperTension (Euro-STAT).
Topics: Acute Disease; Aged; Antihypertensive Agents; Blood Pressure; Clonidine; Emergency Service, Hospital | 2011 |
Cardiogenic shock in an elderly woman: a diagnostic and therapeutic challenge.
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Biopsy; | 2011 |
Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Biomarkers; Blood Urea Nitrogen; CA-125 Antigen; Cohort Stud | 2012 |
CHF treatment: is furosemide on the way out? Rethinking the pulmonary edema cocktail.
Topics: Acute Disease; Analgesics, Opioid; Diuretics; Drug Therapy, Combination; Emergency Treatment; Furose | 2012 |
Lung ultrasound-guided management of acute breathlessness during pregnancy.
Topics: Acute Disease; Adult; Airway Management; Anesthesia, General; Anesthesia, Obstetrical; Cesarean Sect | 2013 |
[Loop diuretics improves diuresis, but not renal function in the intensive care patient with acute renal failure].
Topics: Acute Disease; Diuresis; Furosemide; Humans; Renal Insufficiency; Sodium Potassium Chloride Symporte | 2012 |
Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population.
Topics: Acute Disease; Aged; Aged, 80 and over; Benzazepines; Comparative Effectiveness Research; Creatinine | 2013 |
Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
Topics: Acute Disease; Aged; Biomarkers; Chi-Square Distribution; Diuretics; Drug Administration Schedule; D | 2013 |
Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
Topics: Acute Disease; Aged; Biomarkers; Chi-Square Distribution; Diuretics; Drug Administration Schedule; D | 2013 |
Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
Topics: Acute Disease; Aged; Biomarkers; Chi-Square Distribution; Diuretics; Drug Administration Schedule; D | 2013 |
Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
Topics: Acute Disease; Aged; Biomarkers; Chi-Square Distribution; Diuretics; Drug Administration Schedule; D | 2013 |
Furosemide in acute decompensated heart failure.
Topics: Acute Disease; Diuretics; Dose-Response Relationship, Drug; Furosemide; Heart Failure; Humans; Rando | 2012 |
[Acute myocardial failure in a young man: Q-fever myocarditis].
Topics: Acute Disease; Adult; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antibodies, Bacterial; Cardiomy | 2002 |
Transient hyporeninemic hypoaldosteronism in acute glomerulonephritis.
Topics: Acute Disease; Adrenocorticotropic Hormone; Aldosterone; Child; Diuretics; Furosemide; Glomeruloneph | 2002 |
MRI findings in acute hypertensive encephalopathy.
Topics: Acute Disease; Adolescent; Cerebral Cortex; Diuretics; Electroencephalography; Epilepsy, Tonic-Cloni | 2003 |
[Emergencies seminar: acute pulmonary edema].
Topics: Acute Disease; Analgesics, Opioid; Calcium Channel Blockers; Cardiotonic Agents; Diagnosis, Differen | 2003 |
Effects of acute hypovolaemia by furosemide on tracheal transepithelial potential difference and mucus in dogs.
Topics: Acute Disease; Animals; Anura; Diuretics; Dogs; Furosemide; Hypovolemia; In Vitro Techniques; Male; | 2004 |
More on morphine sulfate and furosemide use by EMS and the risks of adverse outcome.
Topics: Acute Disease; Analgesics, Opioid; Clinical Competence; Diuretics; Emergency Medical Services; Emerg | 2005 |
Biochemical and etiological characteristics of acute hyponatremia in the emergency department.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Drinking; Emerge | 2005 |
Effect of furosemide infusion on renal hemodynamics and angiogenesis gene expression in acute renal ischemia/reperfusion.
Topics: Acute Disease; Animals; Diuretics; Furosemide; Gene Expression Regulation; Hemodynamics; Kidney; Mal | 2006 |
[Diuretic effect of injecting furosemide into low hydraulic resistance point Shuifen along the conception meridian in pigs with acute edema].
Topics: Acupuncture Points; Acute Disease; Animals; Diuretics; Edema; Furosemide; Injections; Injections, In | 2007 |
Flash pulmonary edema: an unusual presentation during orthognathic surgery.
Topics: Acute Disease; Adult; Anesthesia, Intravenous; Female; Follow-Up Studies; Furosemide; Humans; Intrao | 2007 |
Acute colchicine intoxication in a child: a case report.
Topics: Acute Disease; Alopecia; Ataxia; Blood Transfusion; Case Management; Child, Preschool; Colchicine; C | 2007 |
Acute decompensated heart failure.
Topics: Acute Disease; Evidence-Based Medicine; Female; Furosemide; Heart Failure; Humans; Male; Prognosis; | 2007 |
Chlorpromazine and frusemide in treatment of acute left-ventricular failure.
Topics: Acute Disease; Aged; Blood Pressure; Carbon Dioxide; Chlorpromazine; Drug Therapy, Combination; Furo | 1980 |
[Acute fatty liver in pregnancy with consumption coagulopathy].
Topics: Acute Disease; Adult; Ampicillin; Ascites; Disseminated Intravascular Coagulation; Electrolytes; Fat | 1983 |
Right atrial appendectomy reduces the renal response to acute hypervolemia in the rat.
Topics: Acute Disease; Animals; Atrial Natriuretic Factor; Blood Volume; Furosemide; Heart Atria; Kidney; Ma | 1984 |
[Effects of combined use of captopril and furosemide on patients with hypertensive crisis in acute aortic dissection].
Topics: Acute Disease; Aged; Aortic Aneurysm; Aortic Dissection; Captopril; Drug Therapy, Combination; Furos | 1984 |
[Long-term regional arterial therapy of acute surgical diseases of the abdominal organs].
Topics: Acute Disease; Adolescent; Adult; Aged; Animals; Aorta, Abdominal; Catheterization; Diuretics; Dogs; | 1983 |
Severe lithium intoxication treated by forced diuresis.
Topics: Acute Disease; Bipolar Disorder; Diuresis; Female; Furosemide; Glomerular Filtration Rate; Humans; H | 1983 |
[Medical therapy of acute cardiogenic pulmonary edema. Critical review].
Topics: Acute Disease; Blood Pressure; Chlorpromazine; Digitalis; Diuretics; Furosemide; Heart; Humans; Morp | 1984 |
Management of respiratory failure in infants with acute viral bronchiolitis.
Topics: Acute Disease; Bronchiolitis, Viral; Enteral Nutrition; Furosemide; Humans; Infant; Infant, Newborn; | 1984 |
[Comparative evaluation of the effectiveness of forced intra-arterial and intravenous diuresis in acute pancreatitis].
Topics: Acute Disease; Animals; Diuretics; Dogs; Drug Evaluation, Preclinical; Furosemide; Glucose; Glucose | 1984 |
Variations in blood viscosity in patients with acute cardiogenic pulmonary oedema treated with frusemide.
Topics: Acute Disease; Aged; Blood Viscosity; Furosemide; Hematocrit; Humans; Meperidine; Oxygen Inhalation | 1983 |
Action of renal vasodilators in dogs following acute biliary obstruction.
Topics: Acetylcholine; Acute Disease; Angiotensin II; Animals; Bile; Bradykinin; Cholestasis; Diuresis; Dogs | 1984 |
[Modified variant of simultaneous discontinuation of psychotropic drugs (given in combination with diuretics) as a method of abrupt termination therapy for protracted episodes of schizophrenia].
Topics: Acute Disease; Diuretics; Furosemide; Humans; Mannitol; Periodicity; Psychotropic Drugs; Schizophren | 1980 |
[The immediate treatment of acute myocardial infarct].
Topics: Acute Disease; Arrhythmias, Cardiac; First Aid; Furosemide; Hemodynamics; Humans; Isosorbide Dinitra | 1981 |
[Effect of glycerol, mannitol, and lasix on cerebrospinal fluid pressure in the acute period of a stroke].
Topics: Acute Disease; Brain Edema; Brain Ischemia; Cerebral Hemorrhage; Female; Furosemide; Glycerol; Human | 1981 |
Successful treatment of a patient with acute nonlymphoblastic leukemia (ANLL) and anthracycline cardiomyopathy with 4' (9-acridinylamino) methanesulfon-m-anisidide (AMSA).
Topics: Acute Disease; Adult; Aminoacridines; Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Agents; | 1982 |
[Treatment of hypoxemia in acute pneumonia].
Topics: Acute Disease; Adolescent; Adult; Aminophylline; Female; Furosemide; Humans; Hypoxia; Male; Middle A | 1982 |
[Early acute pulmonary oedema happening during peritoneovenous by pass (author's transl)].
Topics: Acute Disease; Adult; Cardiac Output; Furosemide; Humans; Liver Cirrhosis, Alcoholic; Male; Middle A | 1981 |
[Inappropriate anti-diuretic hormone secretion syndrome associated with acute pneumonia].
Topics: Acute Disease; Aged; Furosemide; Humans; Inappropriate ADH Syndrome; Male; Pneumonia; Sodium Chlorid | 1982 |
Combating sodium and potassium imbalance in older patients.
Topics: Acute Disease; Aged; Furosemide; Humans; Hyperkalemia; Hypernatremia; Hypokalemia; Hyponatremia; Pot | 1981 |
Prognostic implications of reduction of left ventricular filling pressure in early transmural acute myocardial infarction.
Topics: Actuarial Analysis; Acute Disease; Aged; Blood Pressure; Digoxin; Female; Furosemide; Heart Ventricl | 1981 |
The acute hemodynamic effect of furosemide in juvenile mitral stenosis.
Topics: Acute Disease; Adolescent; Child; Female; Furosemide; Hemodynamics; Humans; Male; Mitral Valve Steno | 1980 |
[Use of gentamycin and furosemide in acute pyelonephritis (an experimental morphological study)].
Topics: Acute Disease; Animals; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Furosemide; | 1980 |
Evaluation of diuretic therapy by impedance cardiography in acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; Cardiography, Impedance; Diuretics; Edema, Cardiac; Evaluation Studies a | 1980 |
[Comparative evaluation of the protective effect of furantril and bloodletting in experimental pulmonary edema].
Topics: Acute Disease; Animals; Bloodletting; Drug Evaluation, Preclinical; Epinephrine; Furosemide; Pulmona | 1980 |
Treatment of acute carbamazepine intoxication according to its pharmacological properties. Preliminary report.
Topics: Acute Disease; Adolescent; Carbamazepine; Child; Child, Preschool; Furosemide; Humans; Injections, I | 1980 |
Drug induced acute pancreatitis: incidence and severity.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Azathioprine; Didanosine; Estrogens; Female; Furosemi | 1995 |
Inappropriate antidiuretic hormone secretion.
Topics: Acute Disease; Butorphanol; Chronic Disease; Demeclocycline; Drinking Behavior; Furosemide; Humans; | 1994 |
Low-dose atrial natriuretic factor and furosemide in experimental acute congestive heart failure.
Topics: Acute Disease; Angiotensin II; Animals; Atrial Natriuretic Factor; Dogs; Drug Synergism; Drug Therap | 1993 |
[A case of the massive ingestion of furosemide with suicidal intent].
Topics: Acute Disease; Adult; Fluid Therapy; Furosemide; Humans; Male; Poisoning; Suicide, Attempted | 1993 |
Acute myocarditis and left ventricular aneurysm as presentations of systemic lupus erythematosus.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Cardiac Output, Low; Diuretics; Endocarditis; Fever; | 1996 |
Diuretic-induced hypokalaemia inducing torsades de pointes.
Topics: Acute Disease; Child, Preschool; Diuretics; Electrocardiography; Furosemide; Humans; Hypokalemia; Li | 1995 |
Frusemide or nitrates for acute heart failure?
Topics: Acute Disease; Administration, Sublingual; Diuretics; Furosemide; Heart Failure; Hemodynamics; Human | 1996 |
Rapid response to inhaled frusemide in severe acute asthma with hypercapnia.
Topics: Acute Disease; Administration, Inhalation; Asthma; Blood Gas Analysis; Diuretics; Dose-Response Rela | 1997 |
Drug-associated pancreatitis: facts and fiction.
Topics: Acute Disease; Azathioprine; Furosemide; Humans; Pancreatitis; Sulfonamides; Tetracycline | 1997 |
Treatment of acute pulmonary oedema: diuresis or vasodilatation?
Topics: Acute Disease; Diuretics; Furosemide; Humans; Injections, Intravenous; Isosorbide Dinitrate; Pulmona | 1998 |
Acute glomerulonephritis in hepatitis A virus infection.
Topics: Acute Disease; Child; Furosemide; Glomerular Mesangium; Glomerulonephritis; Hepatitis A; Humans; Mal | 1998 |
Iatrogenic acute hyponatraemia in a college athlete.
Topics: Acute Disease; Adult; Confusion; Dehydration; Diagnosis, Differential; Diuretics; Dyspnea; Fluid The | 1998 |
How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines.
Topics: Acute Disease; Aged; Aged, 80 and over; Aldosterone; Atrial Natriuretic Factor; Biomarkers; Diuretic | 1998 |
Pharmacoeconomic comparison of an albumin-furosemide complex versus sequential therapy for renal insufficiency.
Topics: Acute Disease; Combined Modality Therapy; Costs and Cost Analysis; Dialysis; Diuretics; Furosemide; | 1999 |
Acute pulmonary edema complicating ovale malaria.
Topics: Acute Disease; Adult; Animals; Antimalarials; Diuretics; Female; Follow-Up Studies; Furosemide; Huma | 1999 |
Tumor necrosis factor-alpha serum activity during treatment of acute decompensation of cachectic and non-cachectic patients with advanced congestive heart failure.
Topics: Acute Disease; Adult; Aged; Biomarkers; Body Mass Index; Cachexia; Cardiotonic Agents; Digoxin; Diur | 1999 |
Has an intensified treatment in the ambulance of patients with acute severe left heart failure improved the outcome?
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Ambulances; Combined Modality Therapy; Creatine Kinas | 2000 |
Diuretic MAG3 scintigraphy (F0) in acute pyelonephritis: regional parenchymal dysfunction and comparison with DMSA.
Topics: Acute Disease; Child; Child, Preschool; Female; Furosemide; Humans; Infant; Infant, Newborn; Kidney; | 2000 |
Acute congestive heart failure associated with a limited form of systemic sclerosis and primary biliary cirrhosis.
Topics: Acute Disease; Antibody Specificity; Autoantibodies; Autoimmune Diseases; Centromere; Coronary Circu | 2001 |
Selective renal vasodilation and active renal artery perfusion improve renal function in dogs with acute heart failure.
Topics: Acute Disease; Animals; Diuretics; Dogs; Drug Synergism; Furosemide; Heart Failure; Injections; Kidn | 2001 |
Acute effects of moderate dehydration on the hepatic conversion of amino nitrogen into urea nitrogen in healthy men.
Topics: Acute Disease; Adult; Alanine; Cross-Over Studies; Dehydration; Diuretics; Furosemide; Glucagon; Hum | 2001 |
A comparison of unenhanced helical computerized tomography findings and renal obstruction determined by furosemide 99m technetium mercaptoacetyltriglycine diuretic scintirenography for patients with acute renal colic.
Topics: Acute Disease; Adolescent; Adult; Aged; Colic; Diuretics; Female; Furosemide; Humans; Kidney Disease | 2002 |
A case report of acute heart failure caused by a patient delaying taking his diuretic medication.
Topics: Acute Disease; Dental Care for Chronically Ill; Diuretics; Emergency Treatment; Furosemide; Heart Fa | 2002 |
Drug-associated primary acute pancreatitis.
Topics: Acute Disease; Aged; Cyclopenthiazide; Drug Therapy, Combination; Furosemide; Humans; Hypertension; | 1978 |
[Treatment of acute hyperparathyroidism].
Topics: Acute Disease; Adenoma; Adolescent; Diagnosis, Differential; Diuresis; Female; Furosemide; Humans; H | 1975 |
[Treatment of severe hypercalcemia].
Topics: Acute Disease; Calcitonin; Furosemide; Humans; Hypercalcemia; Plicamycin; Renal Dialysis; Water-Elec | 1978 |
[Fatal necrotizing pancreatitis following drowning in a swimming pool].
Topics: Acute Disease; Acute Kidney Injury; Adult; Drowning; Epilepsy; Furosemide; Hemolysis; Humans; Hydroc | 1976 |
Treatment of complicated hypertension.
Topics: Acute Disease; Cerebral Hemorrhage; Cerebrovascular Disorders; Chronic Disease; Coronary Disease; Di | 1977 |
Pulmonary oedema.
Topics: Acute Disease; Aminophylline; Chronic Disease; Furosemide; Humans; Morphine; Pulmonary Edema | 1979 |
Hyponatraemia and severity and outcome of myocardial infarction.
Topics: Acute Disease; Chlorides; Female; Furosemide; Humans; Hypokalemia; Hyponatremia; Male; Middle Aged; | 1979 |
[Treatment of cardiac insufficiency in the acute stage of cardiac infarct].
Topics: Acute Disease; Blood Pressure; Droperidol; Drug Therapy, Combination; Furosemide; Hemodynamics; Huma | 1979 |
Acute therapeutic modalities for experimental vasogenic edema.
Topics: Acetazolamide; Acute Disease; Animals; Brain Edema; Cerebrovascular Disorders; Cold Temperature; Dex | 1979 |
Blood volume prior to and following treatment of acute cardiogenic pulmonary edema.
Topics: Acute Disease; Adult; Aged; Blood Proteins; Blood Volume; Female; Furosemide; Hematocrit; Humans; Ma | 1978 |
[Hemodynamic effects of furosemide in acute myocardial infarct].
Topics: Acute Disease; Adult; Aged; Blood Pressure; Diuresis; Electrocardiography; Female; Furosemide; Heart | 1978 |
[Diazoxide and furosemide in the treatment of hypertensive emergencies (author's transl)].
Topics: Acute Disease; Adult; Aged; Diazoxide; Drug Therapy, Combination; Female; Furosemide; Humans; Hypert | 1978 |
Effect of afterload reduction on plasma volume during acute heart failure.
Topics: Acute Disease; Aged; Blood Pressure; Cardiac Output; Coronary Disease; Diastole; Drug Evaluation; Fe | 1978 |
The ultrastructural effects of acute decompression on the lung of rats: the influence of frusemide.
Topics: Acute Disease; Animals; Capillaries; Decompression Sickness; Female; Furosemide; Hypoxia; Lung; Micr | 1978 |
Increases in plasma oncotic pressure during acute cardiogenic pulmonary edema.
Topics: Acute Disease; Adult; Aged; Blood Proteins; Colloids; Female; Furosemide; Heart Diseases; Hematocrit | 1977 |
What is the role of positive inotropic agents in the treatment of acute myocardial infarction?
Topics: Acute Disease; Cardiac Output; Digitalis Glycosides; Digoxin; Furosemide; Heart Failure; Heart Rate; | 1977 |
Oral furosemide versus conventional therapy for acute poststreptococcal glomerulonephritis in children.
Topics: Acute Disease; Administration, Oral; Adolescent; Child; Child, Preschool; Female; Furosemide; Glomer | 1977 |
Acute pancreatitis secondary to furosemide with associated hyperlipidemia.
Topics: Acute Disease; Adult; Female; Furosemide; Humans; Hyperlipidemias; Pancreatitis | 1977 |
Diuretic effect of furosemide in acute glomerulonephritis.
Topics: Acute Disease; Administration, Oral; Adolescent; Blood Urea Nitrogen; Child; Child, Preschool; Diure | 1976 |
Arterial blood gases in acute pulmonary edema.
Topics: Acidosis; Acute Disease; Aged; Alkalosis, Respiratory; Carbon Dioxide; Female; Furosemide; Humans; M | 1976 |
[Haemodynamic changes in acute myocardial infarction following high doses of furosemide (author's transl)].
Topics: Acute Disease; Blood Pressure; Cardiac Volume; Diuresis; Female; Furosemide; Heart Rate; Hemodynamic | 1976 |
Spironolactone and acute mountain sickness.
Topics: Acute Disease; Adult; Altitude Sickness; Aspirin; Female; Furosemide; Humans; Hypoxia; Male; Middle | 1976 |
[Effect of furanthril on several hemodynamic indices during the acute stage of myocardial infarction].
Topics: Acute Disease; Adult; Aged; Blood Pressure; Female; Furosemide; Heart Failure; Heart Rate; Humans; I | 1976 |
[Principles of current therapy of acute and chronic pneumonia].
Topics: Acute Disease; Aminophylline; Anti-Bacterial Agents; Blood Coagulation; Body Temperature; Chronic Di | 1975 |
Effect of acute volume depletion on blood pressure, plasma renin activity and plasma aldosterone concentration in hypertensive subjects.
Topics: Acute Disease; Adolescent; Adult; Aldosterone; Blood Pressure; Body Fluids; Electrolytes; Female; Fu | 1975 |
Letter: Frusemide-induced pancreatitis?
Topics: Acute Disease; Adult; Female; Furosemide; Humans; Middle Aged; Myocardial Infarction; Pancreatitis | 1975 |
Letter: Acute hyperphosphatemia and acute persistent renal insufficiency induced by oral phosphate therapy.
Topics: Acute Disease; Acute Kidney Injury; Creatinine; Furosemide; Humans; Hypercalcemia; Hyperparathyroidi | 1975 |
Furosemide and chloral hydrate. Adverse drug interaction.
Topics: Acute Disease; Administration, Oral; Aged; Blood Pressure; Chloral Hydrate; Drug Interactions; Femal | 1975 |
Some observations in the management of acute renal failure by massive intravenous frusemide therapy.
Topics: Acute Disease; Acute Kidney Injury; Adult; Child; Furosemide; Humans; Infusions, Parenteral | 1975 |
[Characteristics of treatment of acute exogenous poisoning in middle-aged and old persons].
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antidotes; Female; Furosemide; Humans; Middle A | 1975 |
[Fulminant hepatitis].
Topics: Acute Disease; Adrenal Cortex Hormones; Alkalosis, Respiratory; Blood Transfusion; Brain Edema; Chem | 1975 |
Acute renal failure. Experience with 52 patients treated at Livingstone Hospital.
Topics: Acute Disease; Acute Kidney Injury; Adult; Blood Coagulation Disorders; Female; Furosemide; Humans; | 1976 |
Renal hemodynamic response to furosemide in septic and injured patients.
Topics: Acute Disease; Blood Volume; Furosemide; Glomerular Filtration Rate; Hemodynamics; Humans; Infection | 1976 |
[Acute pulmonary edema without simultaneous acute myocardial infarct].
Topics: Acute Disease; Adult; Aged; Arrhythmias, Cardiac; Female; Furosemide; Heart Arrest; Humans; Hyperten | 1976 |
[The effect of intravenous furosemide on the hemodynamic parameters and colloid osmotic pressure in patients with pulmonary edema].
Topics: Acute Disease; Aged; Drug Evaluation; Female; Furosemide; Hemodynamics; Humans; Lung; Male; Middle A | 1992 |
[Atrial natriuretic factor in patients with cardiac decompensation before and after chronic therapy with an angiotensin-converting enzyme inhibitor].
Topics: Acute Disease; Aged; Atrial Natriuretic Factor; Biomarkers; Digoxin; Drug Therapy, Combination; Enal | 1992 |
Acute mitral regurgitation: physiological and pharmacological considerations in the management of a critically ill patient.
Topics: Acute Disease; Combined Modality Therapy; Critical Illness; Dopamine; Female; Furosemide; Humans; In | 1992 |
Comparative acute ototoxicity of loop diuretic compounds.
Topics: Acute Disease; Animals; Bumetanide; Chinchilla; Cochlea; Diuretics; Dose-Response Relationship, Drug | 1991 |
Acute hypokalemia and inducibility of ventricular tachyarrhythmia in a nonischemic canine model.
Topics: Acute Disease; Animals; Dogs; Female; Furosemide; Hypokalemia; Insulin; Isoproterenol; Male; Membran | 1991 |
[Voluntary poisoning by Cortinarius orellanus: usefulness of an original early treatment after determination of orellanine in the biological fluids and tissues].
Topics: 2,2'-Dipyridyl; Acute Disease; Acute Kidney Injury; Adult; Agaricales; Amino Acids; Ascorbic Acid; B | 1991 |
Hyperkalemia in acute glomerulonephritis due to transient hyporeninemic hypoaldosteronism.
Topics: Acute Disease; Adolescent; Adult; Fludrocortisone; Furosemide; Glomerulonephritis; Humans; Hyperkale | 1990 |
Transient renal acidification defect during acute infantile diarrhea: the role of urinary sodium.
Topics: Acidosis, Renal Tubular; Acute Disease; Age Factors; Diarrhea, Infantile; Fluid Therapy; Furosemide; | 1990 |
[A case of acute rhabdomyolysis and acute renal insufficiency caused by the simultaneous use of furosemide and bezafibrate].
Topics: Acute Disease; Acute Kidney Injury; Aged; Bezafibrate; Female; Furosemide; Humans; Rhabdomyolysis | 1990 |
Hypokalemia in rats produces resistance to dysrhythmias under halothane anesthesia.
Topics: Acute Disease; Anesthesia, Inhalation; Animals; Arrhythmias, Cardiac; Cardiac Complexes, Premature; | 1989 |
Neuroendocrine response in acute heart failure and the influence of treatment.
Topics: Acute Disease; Aged; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; C | 1989 |
Chlorpromazine and frusemide in the acute management of severe hypertension.
Topics: Acute Disease; Adult; Chlorpromazine; Emergencies; Female; Furosemide; Humans; Hypertension; Infusio | 1989 |
Chagas' disease.
Topics: Acute Disease; Chagas Cardiomyopathy; Chagas Disease; Diet, Sodium-Restricted; Furosemide; Humans; I | 1986 |
Transthoracic electrical impedance at 1 and 100 kHz--a means for separating thoracic fluid compartments?
Topics: Acute Disease; Aged; Body Fluid Compartments; Body Fluids; Cardiac Catheterization; Electric Conduct | 1987 |
[Treatment of 40 cases of acute high altitude disease with complicating cerebral edema].
Topics: Acute Disease; Adult; Altitude Sickness; Brain Edema; Dexamethasone; Furosemide; Humans; Hypoxia; Ma | 1987 |
[Acute rhabdomyolysis in heroin addiction].
Topics: Acute Disease; Acute Kidney Injury; Adult; Dopamine; Furosemide; Heroin Dependence; Humans; Male; Rh | 1986 |
[Furosemide and pancreatitis].
Topics: Acute Disease; Female; Furosemide; Humans; Male; Pancreatitis | 1986 |
[Acute granulomatous interstitial nephritis and hepatitis caused by drugs. Possible role of an allopurinol-furosemide combination].
Topics: Acute Disease; Allopurinol; Atenolol; Biopsy; Chemical and Drug Induced Liver Injury; Female; Furose | 1986 |
Poststreptococcal acute glomerulonephritis.
Topics: Acute Disease; Adult; Antistreptolysin; Complement System Proteins; Edema; Furosemide; Glomerular Fi | 1985 |
[Acute drug-induced pancreatitis].
Topics: Acute Disease; Asparaginase; Azathioprine; Chlorothiazide; Drug-Related Side Effects and Adverse Rea | 1985 |
Impaired potassium and magnesium homeostasis in acute tubulo-interstitial nephritis.
Topics: Acute Disease; Adolescent; Amino Acids; Fanconi Syndrome; Female; Furosemide; Glycosuria; Homeostasi | 1985 |
[Acute iodine poisoning associated with sialadenitis, allergic vasculitis and conjunctivitis following administration of iodine-containing contrast media].
Topics: Acute Disease; Aged; Conjunctivitis, Allergic; Contrast Media; Drug Hypersensitivity; Female; Furose | 1985 |
Blood-gas exchange after frusemide in acute pulmonary oedema.
Topics: Acute Disease; Administration, Oral; Aged; Blood Gas Analysis; Blood Pressure; Blood Volume; Carbon | 1971 |
Frusemide and acute pulmonary oedema.
Topics: Acute Disease; Furosemide; Humans; Pulmonary Edema | 1971 |
Frusemide and acute pulmonary oedema.
Topics: Acute Disease; Blood Pressure; Furosemide; Humans; Injections, Intravenous; Lung Compliance; Oxygen | 1971 |
Initial metabolic and hormonal response to acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; Blood Glucose; Blood Specimen Collection; Catecholamines; Cholesterol; C | 1974 |
Treatment of acute hypercalcemia with furosemide.
Topics: Acute Disease; Adult; Aged; Calcium; Diuresis; Female; Furosemide; Humans; Hypercalcemia; Male; Midd | 1973 |
[Use of furosemide in treatment of acute renal failure in the course of glomerulonephritis in children].
Topics: Acute Disease; Acute Kidney Injury; Adolescent; Age Factors; Child; Child, Preschool; Drug Evaluatio | 1974 |
[The acute hypercalcemic crisis in primary hyperparathyroidism (author's transl)].
Topics: Acute Disease; Adenoma; Blood Volume; Central Venous Pressure; Dihydrotachysterol; Female; Furosemid | 1974 |
The Fairley test: an aid in the diagnosis of pyelonephritis in paraplegia.
Topics: Acute Disease; Adolescent; Adult; Aged; Bacteriological Techniques; Bacteriuria; Deoxyribonucleases; | 1974 |
Myoglobinuria precipitated by viral infection.
Topics: Acute Disease; Adult; Antibodies, Viral; Coxsackievirus Infections; Enterovirus; Furosemide; Humans; | 1974 |
Hypertensive crisis.
Topics: Acute Disease; Cerebrovascular Circulation; Cerebrovascular Disorders; Diagnosis, Differential; Diaz | 1974 |
Preservation of ischemic myocardium.
Topics: Acute Disease; Blood Pressure; Cardiac Output; Coronary Circulation; Depression, Chemical; Digitalis | 1974 |
High-dose furosemide (Lasix) in renal insufficiency.
Topics: Acute Disease; Acute Kidney Injury; Adult; Chronic Disease; Diet, Sodium-Restricted; Female; Furosem | 1972 |
[Discussion of the treatment of hypercalcemia with furosemide].
Topics: Acute Disease; Calcitonin; Calcium; Diuretics; Furosemide; Humans; Hypercalcemia; Injections, Intrav | 1973 |
Interstitial viral pneumonitis complicated by severe respiratory failure. Successful management using intensive dehydration and steroids.
Topics: Acute Disease; Aged; Diuretics; Female; Furosemide; Humans; Hypoxia; Male; Mannitol; Methylprednisol | 1973 |
[Diuretics in acute glomerulonephritis?].
Topics: Acute Disease; Diuretics; Ethacrynic Acid; Furosemide; Glomerulonephritis; Humans; Kidney Diseases; | 1973 |
[Acute left heart failure, pulmonary edema].
Topics: Acute Disease; Aged; Furosemide; Heart Failure; Humans; Lanatosides; Male; Morphine; Oxygen Inhalati | 1973 |
An analysis of acute glomerulonephritis in children treated conventionally in comparison to intravenous furosemide.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Female; Furosemide; Glomerulonephritis; Humans; | 1973 |
[Acute myocardial infarction (author's transl)].
Topics: Acute Disease; Adult; Aged; Blood Pressure; Cardiac Catheterization; Digoxin; Female; Furosemide; Ge | 1974 |
[Suicidal digoxin intoxication with hyperkalaemia: report of a case (author's transl)].
Topics: Acute Disease; Adult; Atropine; Bradycardia; Digoxin; Electrocardiography; Female; Furosemide; Human | 1974 |
[Use of furosemide in treatment of acute renal failure in the course of glomerulonephritis in children].
Topics: Acute Disease; Acute Kidney Injury; Adolescent; Age Factors; Child; Child, Preschool; Drug Evaluatio | 1974 |
A coronary care unit: results of the first year of operation.
Topics: Acute Disease; Adult; Aged; Anticoagulants; Arrhythmias, Cardiac; Digitoxin; Electrocardiography; Fe | 1968 |
The renal functional response to furosemide in children with acute glomerulonephritis.
Topics: Acute Disease; Aminohippuric Acids; Body Water; Creatinine; Furosemide; Glomerular Filtration Rate; | 1972 |
Successful use of oral diazoxide in the treatment of severe toxaemia of pregnancy.
Topics: Acute Disease; Administration, Oral; Adult; Albuminuria; Blood Glucose; Diazoxide; Female; Furosemid | 1972 |
Acute renal failure and open heart surgery.
Topics: Acute Disease; Acute Kidney Injury; Adolescent; Adult; Age Factors; Aged; Autopsy; Cardiac Surgical | 1972 |
[Diuresis and diuretics].
Topics: Acetazolamide; Acute Disease; Agranulocytosis; Anuria; Biological Transport; Blood Platelet Disorder | 1971 |
Methadone-induced pulmonary edema.
Topics: Acute Disease; Administration, Oral; Adult; Coma; Female; Furosemide; Heroin; Humans; Hydrocortisone | 1971 |
Left heart failure in acute myocardial infarction. A clinical, haemodynamic and therapeutic study.
Topics: Acute Disease; Aged; Arrhythmias, Cardiac; Arteries; Aspartate Aminotransferases; Blood Pressure; Cl | 1970 |
Haemodynamic changes after a diuresia in acute myocardial infarction.
Topics: Acute Disease; Blood Pressure; Cardiac Output; Cardiac Volume; Diuresis; Furosemide; Hemodynamics; H | 1970 |
[Diuretic effect of furosemide in acute oliguria in burned dogs].
Topics: Acute Disease; Animals; Anuria; Burns; Diuresis; Dogs; Furosemide; Injections, Intravenous; Kidney | 1970 |
[Trial of the furosemide-reserpine combination in severe arterial hypertension].
Topics: Acute Disease; Adult; Female; Furosemide; Humans; Hypertension; Male; Middle Aged; Reserpine | 1970 |
[Effectiveness of induced diuresis in the treatment of acute poisoning].
Topics: Acute Disease; Diuresis; Female; Furosemide; Humans; Poisoning | 1968 |
A diuretic approach to acute withdrawal from alcohol.
Topics: Acute Disease; Alcoholism; Body Fluids; Body Weight; Chlorides; Diuresis; Erythrocytes; Furosemide; | 1969 |
Use in furosemide in the treatment of acute glomerulonephritis.
Topics: Acute Disease; Furosemide; Glomerulonephritis; Humans | 1969 |
The effect of willow leaf extracts on human leukemic cells in vitro.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Agents, Phytogenic; Benzyl Alcohols; Cell Sur | 2003 |